UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-22883
ARK ETF Trust
(Exact name of registrant as specified in charter)
c/o ARK Investment Management LLC
200 Central Avenue, Suite 1850
St. Petersburg, FL 33701
(Address of principal executive offices) (Zip code)
Corporation Service Company
2711 Centerville Road
Suite 400
Wilmington, DE 19808
(Name and address of agent for service)
Registrant’s telephone number, including area code: (212) 426-7040
Date of fiscal year end: July 31
Date of reporting period: January 31, 2022
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Item 1. Reports to Stockholders.
| (a) | The Report to Shareholders is attached herewith. |
ARK ETF TRUST
SEMI-ANNUAL REPORT
JANUARY 31, 2022
INVESTING AT THE PACE OF INNOVATION
ARK Genomic Revolution ETF (ARKG)
ARK Autonomous Technology & Robotics ETF (ARKQ)
ARK Innovation ETF (ARKK)
ARK Next Generation Internet ETF (ARKW)
ARK Fintech Innovation ETF (ARKF)
ARK Space Exploration & Innovation ETF (ARKX)
ARK Transparency ETF (CTRU)
The 3D Printing ETF (PRNT)
The ARK Israel Innovative Technology ETF (IZRL)
ARK Invest | 200 Central Avenue, Suite 1850, St. Petersburg, FL 33701 | 212.426.7040 | info@ark-invest.com | ark-funds.com
| | | | | | 1 | | |
| | | | | | 2 | | |
| | | | | | 4 | | |
| Schedule of Investments | | | | | | | |
| | | | | | 6 | | |
| | | | | | 9 | | |
| | | | | | 11 | | |
| | | | | | 14 | | |
| | | | | | 16 | | |
| | | | | | 18 | | |
| | | | | | 20 | | |
| | | | | | 22 | | |
| | | | | | 24 | | |
| | | | | | 26 | | |
| | | | | | 29 | | |
| | | | | | 32 | | |
| | | | | | 37 | | |
| | | | | | 46 | | |
| | | | | | 51 | | |
| | | | | | 52 | | |
This report should be read in conjunction with the Trust’s prospectus.
The principal risks of investing in the ARK ETFs include: Market Risk. The value of the Funds’ assets will fluctuate as the markets in which the Funds invest fluctuate. The value of the Funds’ investments may decline, sometimes rapidly and unpredictably, simply because of economic changes or other events, such as inflation (or expectations for inflation), interest rates, global demand for particular products or resources, natural disasters or events, exchange trading suspensions and closures (including exchanges of a Fund’s underlying securities), infectious disease outbreaks or pandemics, terrorism, regulatory events and government controls, that affect large portions of the market. Equity Securities Risk: The value of the equity securities the Funds hold may fall due to general market and economic conditions, perceptions regarding the industries in which the issuers of securities the Funds hold participate or factors relating to specific companies in which the Funds invest (e.g., litigation or government regulation), among other factors. Equity securities may also be particularly sensitive to general movements in the stock market, and a decline in the broader market may affect the value of the Fund’s equity investments. The Funds may invest in stock of, warrants to purchase stock of, and other interests in special purpose acquisition companies (SPACs) or similar special purposes entities. A SPAC is a publicly traded company that raises investment capital for the purpose of acquiring or merging with an existing company. Investments in SPACs and similar entities are subject to a variety of risks beyond those associated with other equity securities. Because SPACs and similar entities do not have any operating history or ongoing business other than seeking acquisitions, the value of their securities is particularly dependent on the ability of the SPAC’s management to identify a merger target and complete an acquisition. Until an acquisition or merger is completed, a SPAC generally invests its assets, less a portion retained to cover expenses, in U.S. government securities, money market securities and cash and does not typically pay dividends in respect of its common stock. As a result, it is possible that an investment in a SPAC may lose value. Foreign Securities Risk: Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities such as risks of currency exchange rates, differences in foreign accounting and legal standards, the availability of less reliable financial information, and government restrictions on repatriation of capital. Geopolitical risks, including those arising from trade tension and/or the imposition of trade tariffs, terrorist activity or acts of civil or international hostility, are increasing. For instance, military conflict and escalating tensions between countries could result in geopolitical instability and adversely affect the global economy or specific markets. Strategic competition between the US and China and resulting tensions have also contributed to uncertainty in the geopolitical and regulatory landscapes. Similarly, other events outside of the Trust's control, including natural disasters, climate change-related events, pandemics (such as the COVID-19 pandemic) or health crises may arise from time to time and be accompanied by governmental actions that may increase international tension. Any such events and responses, including regulatory developments, may cause significant volatility and declines in the global markets, disproportionate impacts to certain industries or sectors, disruptions to commerce (including to economic activity, travel and supply chains), loss of life and property damage, and may adversely affect the global economy or capital markets and may cause the Trust's assets to decline. Health Care Sector Risk: Companies in the health care sector may be adversely affected by government regulations and government health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Consumer Discretionary Risk: The consumer discretionary sector may be affected by changes in domestic and international economies, exchange and interest rates, competition, consumers’ disposable income and consumer preferences, social trends and marketing campaigns. Industrials Sector Risk: Companies in the industrials sector may be adversely affected by changes in government regulation (such as through the imposition or removal of tariffs), world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk: Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. The markets in which many information technology companies compete face rapidly evolving industry standards and government regulations, frequent new service and product announcements, introductions and enhancements, and changing customer demands. Communications Sector Risk: Communication companies are particularly vulnerable to the potential obsolescence of products and services due to technological advancement and the innovation of competitors. Companies in the communications sector may also be affected by other competitive pressures, such as pricing competition, as well as research and development costs, substantial capital requirements and government regulation. Financial Technology Sector Risk: Companies in the financial technology (“FinTech”) sector that are developing financial technologies that seek to disrupt or displace established financial institutions generally face competition from much larger and more established firms. FinTech companies may not currently derive any revenue, and there is no assurance that such companies will derive any revenue from innovative technologies in the future. Cryptocurrency Investment Risk: ARKK and ARKW may have exposure to cryptocurrency, such as bitcoin, indirectly through an investment in a grantor trust (e.g., the Grayscale Bitcoin Trust (BTC)) that will experience any associated volatility of the underlying cryptocurrency. Shares of BTC may trade at a significant premium or discount to net asset value (“NAV”). To the extent BTC trades at a discount to NAV, the value of a Fund’s investment in BTC would typically decrease. ARKW may also have exposure to bitcoin through other pooled investment vehicles that invest in bitcoin, such as exchange-traded funds that are domiciled and listed for trading in Canada. The Funds’ exposure to cryptocurrencies may change over time and, accordingly, such exposure may not always be present in the Funds’ portfolios. Cryptocurrencies such as bitcoin are not “fiat” currencies of any central bank or government and currently are not subject to the authority of any central bank or government authority and are therefore not backed by any government, and regulatory and tax treatment of cryptocurrencies continues to develop. Disruptive Innovation Risk: Companies that the advisor believes create and capitalize on disruptive innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. The Fund may invest in a company that does not currently derive any revenue from disruptive innovations or technologies, and there is no assurance that a company will derive any revenue from disruptive innovations or technologies in the future. Non-Diversified Risk. As a non-diversified investment company, a Fund is subject to the risk that it will be more volatile than a diversified fund because the Fund may invest a relatively higher proportion of its assets in a relatively smaller number of issuers or may invest a larger proportion of its assets in a single issuer. As a result, the gains and losses on a single investment may have a greater impact on a Fund’s NAV and may make the Fund more volatile than more diversified funds. Market Trading Risk. Each Fund faces numerous market trading risks, including disruptions to the creation and redemption processes
of the Fund, losses from trading in secondary markets, the existence of extreme market volatility, the potential lack of an active trading market for the Fund’s shares due to market stress, or trading halts impacting the Shares or the Fund’s underlying securities, which may result in the Fund’s shares trading at a significant premium or discount to NAV. Please see the ARK ETFs’ current prospectuses for more detailed descriptions of the risks of investing in the ARK ETFs.
The views expressed in the Shareholder Letter are those of ARK Investment Management LLC (“ARK”) as of January 31, 2022. The Shareholder Letter may not necessarily reflect the views or holdings on the date this Semi-Annual Report is first published or anytime thereafter. The information in the Shareholder Letter may change, and the ARK ETFs disclaim any obligation to advise shareholders of any such changes. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party.
Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security. Please visit www.ark-funds.com for the most current list of portfolio holdings for the ARK ETFs.
Shareholder Letter
(Unaudited)
Dear Shareholder:
This Semi-Annual Report for the ARK ETF Trust covers the period from August 1, 2021 through January 31, 2022, for each ARK exchange traded fund (“ETF” or collectively, “ARK ETFs”). The ARK ETF Trust, as of the period of this report, consists of six actively managed theme-based ETFs and three index-based ETFs:
ETF | | | Commencement Date | |
ARK Genomic Revolution ETF | | | 10/31/14 | |
ARK Autonomous Technology & Robotics ETF | | | 9/30/14 | |
ARK Innovation ETF | | | 10/31/14 | |
ARK Next Generation Internet ETF | | | 9/30/14 | |
ARK Fintech Innovation ETF | | | 2/4/19 | |
ARK Space Exploration & Innovation ETF | | | 3/30/21 | |
ARK Transparency ETF | | | 12/8/21 | |
The 3D Printing ETF | | | 7/19/16 | |
The ARK Israel Innovative Technology ETF | | | 12/5/17 | |
ARK Investment Management LLC (“ARK”), the investment advisor to the ARK ETFs, specializes in thematic investing in disruptive innovation. The ARK ETFs include portfolio companies that we believe are leading and benefiting from five innovation platforms: artificial intelligence (AI), energy storage, robotics, DNA sequencing, and blockchain technology. According to our research, these innovation platforms will transform our lives and the global economy radically, scaling their equity market capitalizations from roughly $10 trillion today to more than $200 trillion in 2030.
Investment strategies geared to the future, like ours, evaluate complex dynamics that can evolve rapidly. Take the coronavirus pandemic. Seemingly overnight, demand for innovations in such diverse areas as DNA sequencing, artificial intelligence, and e-commerce surged. In response, ARK’s analysts pivoted quickly and focused on the accelerated rate of adoption of the five innovation platforms and their fourteen underlying technologies. As a result, we increased our exposure to digital wallets, electric vehicles, genomic sequencing, molecular diagnostics, 3D printing, and drone delivery/robotic logistics. In our view, the coronavirus crisis permanently changed the way the world works, catapulting consumers and businesses into the digital age much faster and deeper than otherwise would have been the case. While many still are dismissing innovation stocks as “stay at home”, we believe this behavior glosses over a crucial point: innovation solves problems in a way that consumers and businesses adopt with relief, enthusiasm, and delight.
For this reason, ARK places significant focus on our five-year investment time horizon, communicating constantly with our clients that innovation solves problems and is expected to transform human lives at an accelerated rate during the next five to ten years. We also reiterate that we take advantage of volatility during corrections and concentrate our portfolios toward our highest conviction stocks. We believe the result of engaging with our clients has been asset retention better than many observers might have anticipated, suggesting that on balance, investors understand our active management investment process and long-term investment time horizon.
On the following pages, you will find information relating to your ARK ETF investment. If you have any questions, I encourage you to contact your financial advisor or ARK directly. You can find additional information, including our daily portfolio holdings, on the ARK ETF website located at: www.ark-funds.com.
We appreciate the opportunity to help you meet your investment goals and thank you for enabling us to invest for you at the pace of innovation!
Sincerely,
Catherine D. Wood
Chief Investment Officer and Chief Executive Officer
ARK Investment Management LLC
Shareholder Expense Examples
As a shareholder of an ARK ETF (each, a “Fund” and collectively, “Funds”) you incur two types of costs: (1) transaction costs for purchasing and selling shares; and (2) ongoing costs, including management fees and other Fund expenses. The following examples are intended to help you understand your ongoing costs (in dollars and cents) of investing in the Funds and to compare these costs with the ongoing costs of investing in other funds.
The examples below are based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (August 1, 2021 through January 31, 2022).
Actual Expenses
The first line under each Fund in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Fund under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during the period.
Hypothetical Example for Comparison Purposes
The second line under each Fund in the table below provides information about hypothetical account values and hypothetical expenses based on each Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate your actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund to other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of Fund shares. Therefore, the second line under each Fund in the table is useful in comparing ongoing Fund costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
| | | Beginning Account Value 8/1/2021 | | | Ending Account Value 1/31/2022 | | | Annualized Expense Ratios for the Period | | | Expenses Paid During the Period(a) | |
ARK Genomic Revolution ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 592.90 | | | | | | 0.75% | | | | | $ | 3.01 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.42 | | | | | | 0.75% | | | | | $ | 3.82 | | |
ARK Autonomous Technology & Robotics ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 820.30 | | | | | | 0.75% | | | | | $ | 3.44 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.42 | | | | | | 0.75% | | | | | $ | 3.82 | | |
ARK Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 633.50 | | | | | | 0.75% | | | | | $ | 3.09 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.42 | | | | | | 0.75% | | | | | $ | 3.82 | | |
ARK Next Generation Internet ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 661.40 | | | | | | 0.75% | | | | | $ | 3.14 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.42 | | | | | | 0.75% | | | | | $ | 3.82 | | |
ARK Fintech Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 640.00 | | | | | | 0.75% | | | | | $ | 3.10 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.42 | | | | | | 0.75% | | | | | $ | 3.82 | | |
ARK Space Exploration & Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 804.90 | | | | | | 0.70% | | | | | $ | 3.18 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.68 | | | | | | 0.70% | | | | | $ | 3.57 | | |
ARK Transparency ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 846.50 | | | | | | 0.55% | | | | | $ | 0.77(b) | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,022.43 | | | | | | 0.55% | | | | | $ | 2.80 | | |
The 3D Printing ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 794.40 | | | | | | 0.66% | | | | | $ | 2.99 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.88 | | | | | | 0.66% | | | | | $ | 3.36 | | |
Shareholder Expense Examples (continued)
(Unaudited)
| | | Beginning Account Value 8/1/2021 | | | Ending Account Value 1/31/2022 | | | Annualized Expense Ratios for the Period | | | Expenses Paid During the Period(a) | |
The ARK Israel Innovative Technology ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 831.20 | | | | | | 0.49% | | | | | $ | 2.26 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,022.74 | | | | | | 0.49% | | | | | $ | 2.50 | | |
(a)
Expenses are equal to each Fund’s annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (the number of days in the period, then divided by 365).
(b)
ARK Transparency ETF commenced operations on December 8, 2021. Expenses are equal to the Fund’s annualized expense ratio, multiplied by the average account value over the period since the commencement of the Fund’s operations, multiplied by 55/365 (the number of days in the period, then divided by 365).
Sector Diversification (as a percentage of total investments)
ARK Genomic Revolution ETF (ARKG)
| ■ | | | Health Care | | | | | 95.3% | | |
| ■ | | | Information Technology | | | | | 3.7 | | |
| ■ | | | Financials | | | | | 0.6 | | |
| ■ | | | Materials | | | | | 0.4 | | |
| | | | Money Market Fund | | | | | 0.0(a) | | |
| | | | | | | | | 100.0 | | |
(a)
Less than 0.05%
ARK Autonomous Technology &
Robotics ETF (ARKQ)
| ■ | | | Industrials | | | | | 35.8% | | |
| ■ | | | Information Technology | | | | | 34.4 | | |
| ■ | | | Consumer Discretionary | | | | | 19.7 | | |
| ■ | | | Communication Services | | | | | 8.9 | | |
| ■ | | | Health Care | | | | | 1.0 | | |
| ■ | | | Money Market Fund | | | | | 0.2 | | |
| | | | | | | | | 100.0 | | |
ARK Innovation ETF (ARKK)
| ■ | | | Information Technology | | | | | 33.0% | | |
| ■ | | | Health Care | | | | | 32.8 | | |
| ■ | | | Communication Services | | | | | 14.9 | | |
| ■ | | | Consumer Discretionary | | | | | 11.3 | | |
| ■ | | | Financials | | | | | 6.9 | | |
| ■ | | | Industrials | | | | | 1.0 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
ARK Next Generation
Internet ETF (ARKW)
| ■ | | | Information Technology | | | | | 36.5% | | |
| ■ | | | Communication Services | | | | | 24.5 | | |
| ■ | | | Financials | | | | | 16.9 | | |
| ■ | | | Consumer Discretionary | | | | | 15.4 | | |
| ■ | | | Health Care | | | | | 6.6 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
ARK Fintech Innovation ETF (ARKF)
| ■ | | | Information Technology | | | | | 45.6% | | |
| ■ | | | Financials | | | | | 27.4 | | |
| ■ | | | Consumer Discretionary | | | | | 12.0 | | |
| ■ | | | Communication Services | | | | | 7.0 | | |
| ■ | | | Health Care | | | | | 4.0 | | |
| ■ | | | Real Estate | | | | | 3.9 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
ARK Space Exploration &
Innovation ETF (ARKX)
| ■ | | | Industrials | | | | | 51.8% | | |
| ■ | | | Information Technology | | | | | 26.5 | | |
| ■ | | | Communication Services | | | | | 8.1 | | |
| ■ | | | Equity Fund | | | | | 7.9 | | |
| ■ | | | Consumer Discretionary | | | | | 5.6 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
Sector Diversification (as a percentage of total investments) (concluded)
ARK Transparency ETF (CTRU)
| | | | |
| ■ | | | Information Technology | | | | | 44.9% | | |
| ■ | | | Consumer Discretionary | | | | | 23.5 | | |
| ■ | | | Industrials | | | | | 8.3 | | |
| ■ | | | Health Care | | | | | 7.5 | | |
| ■ | | | Communication Services | | | | | 6.8 | | |
| ■ | | | Consumer Staples | | | | | 4.5 | | |
| ■ | | | Materials | | | | | 2.2 | | |
| ■ | | | Financials | | | | | 2.0 | | |
| ■ | | | Money Market Fund | | | | | 0.3 | | |
| | | | | | | | | 100.0 | | |
The 3D Printing ETF (PRNT)
| ■ | | | Information Technology | | | | | 46.4% | | |
| ■ | | | Industrials | | | | | 29.3 | | |
| ■ | | | Health Care | | | | | 9.2 | | |
| ■ | | | Consumer Discretionary | | | | | 5.2 | | |
| ■ | | | Money Market Fund | | | | | 3.6 | | |
| ■ | | | Materials | | | | | 3.4 | | |
| ■ | | | Financial Services | | | | | 2.8 | | |
| ■ | | | Consumer Staples | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
The ARK Israel Innovative
Technology ETF (IZRL)
| ■ | | | Information Technology | | | | | 55.8% | | |
| ■ | | | Health Care | | | | | 18.3 | | |
| ■ | | | Industrials | | | | | 10.3 | | |
| ■ | | | Communication Services | | | | | 9.4 | | |
| ■ | | | Consumer Discretionary | | | | | 6.2 | | |
| | | | | | | | | 100.0 | | |
ARK Genomic Revolution ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 99.7% | | | | | | | | | | | | | |
Biotechnology – 59.0% | | | | | | | | | | | | | |
AquaBounty Technologies, Inc.* | | | | | 3,357,823 | | | | | $ | 5,943,347 | | |
Arcturus Therapeutics Holdings, Inc.*† | | | | | 2,463,076 | | | | | | 64,360,176 | | |
Beam Therapeutics, Inc.* | | | | | 2,258,626 | | | | | | 156,319,505 | | |
Burning Rock Biotech Ltd. (China)*(a) | | | | | 1,472,695 | | | | | | 13,254,255 | | |
CareDx, Inc.*† | | | | | 3,623,433 | | | | | | 151,459,499 | | |
Cellectis SA (France)*†(a) | | | | | 2,898,410 | | | | | | 17,999,126 | | |
CRISPR Therapeutics AG (Switzerland)* | | | | | 2,073,934 | | | | | | 132,213,293 | | |
Editas Medicine, Inc.* | | | | | 999,620 | | | | | | 19,032,765 | | |
Evogene Ltd. (Israel)*† | | | | | 2,296,202 | | | | | | 3,191,721 | | |
Exact Sciences Corp.* | | | | | 4,661,181 | | | | | | 355,927,781 | | |
Fate Therapeutics, Inc.* | | | | | 4,368,208 | | | | | | 181,324,314 | | |
Ginkgo Bioworks Holdings, Inc.* | | | | | 18,381,781 | | | | | | 109,923,050 | | |
Incyte Corp.* | | | | | 1,639,416 | | | | | | 121,857,791 | | |
Intellia Therapeutics, Inc.* | | | | | 1,872,413 | | | | | | 177,074,097 | | |
Invitae Corp.* | | | | | 6,052,287 | | | | | | 68,027,706 | | |
Ionis Pharmaceuticals, Inc.* | | | | | 7,017,770 | | | | | | 223,165,086 | | |
Iovance Biotherapeutics, Inc.* | | | | | 3,138,068 | | | | | | 52,248,832 | | |
Nurix Therapeutics, Inc.* | | | | | 404,681 | | | | | | 7,535,160 | | |
Organovo Holdings, Inc.* | | | | | 209,508 | | | | | | 653,665 | | |
Recursion Pharmaceuticals, Inc., Class A* | | | | | 2,920,697 | | | | | | 34,581,053 | | |
Regeneron Pharmaceuticals, Inc.* | | | | | 69,282 | | | | | | 42,164,332 | | |
Repare Therapeutics, Inc. (Canada)*† | | | | | 2,971,279 | | | | | | 45,846,835 | | |
Surface Oncology, Inc.*† | | | | | 5,410,150 | | | | | | 20,288,063 | | |
Twist Bioscience Corp.* | | | | | 1,948,118 | | | | | | 115,757,172 | | |
Veracyte, Inc.* | | | | | 2,087,385 | | | | | | 63,477,378 | | |
Vertex Pharmaceuticals, Inc.* | | | | | 747,966 | | | | | | 181,793,136 | | |
Verve Therapeutics, Inc.* | | | | | 1,682,741 | | | | | | 48,496,596 | | |
Total Biotechnology | | | | | | | | | | | 2,413,915,734 | | |
Chemicals – 0.4% | | | | | | | | | | | | | |
Zymergen, Inc.* | | | | | 3,242,127 | | | | | | 16,859,060 | | |
Electronic Equipment, Instruments & Components – 1.2% | |
908 Devices, Inc.*† | | | | | 3,107,331 | | | | | | 49,157,976 | | |
Financial Services – 0.6% | | | | | | | | | | | | | |
Dynamics Special Purpose Corp., Class A*† | | | | | 2,354,418 | | | | | | 23,308,738 | | |
Health Care Equipment & Supplies – 1.7% | |
Butterfly Network, Inc.* | | | | | 7,583,314 | | | | | | 43,983,221 | | |
Cerus Corp.* | | | | | 4,534,872 | | | | | | 24,306,914 | | |
Total Health Care Equipment & Supplies | | | | | | | | | | | 68,290,135 | | |
Health Care Providers & Services – 7.9% | |
1Life Healthcare, Inc.* | | | | | 5,444,619 | | | | | | 60,761,948 | | |
Accolade, Inc.*† | | | | | 5,013,040 | | | | | | 95,749,064 | | |
Castle Biosciences, Inc.* | | | | | 1,208,744 | | | | | | 52,278,178 | | |
Signify Health, Inc., Class A*† | | | | | 8,657,468 | | | | | | 115,404,049 | | |
Total Health Care Providers & Services | | | | | | | | | | | 324,193,239 | | |
Health Care Technology – 11.0% | | | | | | | | | | | | | |
Schrodinger, Inc.* | | | | | 2,927,222 | | | | | | 82,986,743 | | |
Teladoc Health, Inc.* | | | | | 4,166,263 | | | | | | 319,594,035 | | |
Veeva Systems, Inc., Class A* | | | | | 210,318 | | | | | | 49,748,620 | | |
Total Health Care Technology | | | | | | | | | | | 452,329,398 | | |
Investments | | | Shares | | | Value | |
Life Sciences Tools & Services – 14.2% | |
10X Genomics, Inc., Class A* | | | | | 469,230 | | | | | $ | 45,172,772 | | |
Adaptive Biotechnologies Corp.* | | | | | 5,674,389 | | | | | | 98,961,344 | | |
Berkeley Lights, Inc.*† | | | | | 3,524,580 | | | | | | 34,223,672 | | |
Codexis, Inc.* | | | | | 3,228,138 | | | | | | 66,176,829 | | |
Compugen Ltd. (Israel)* | | | | | 3,318,581 | | | | | | 11,780,963 | | |
Pacific Biosciences of California, Inc.*† | | | | | 13,026,974 | | | | | | 145,641,569 | | |
Personalis, Inc.*† | | | | | 5,237,429 | | | | | | 59,654,316 | | |
Quantum-Si, Inc.*† | | | | | 11,749,374 | | | | | | 56,279,502 | | |
SomaLogic, Inc.* | | | | | 7,444,548 | | | | | | 63,874,222 | | |
Total Life Sciences Tools & Services | | | | | | | | | | | 581,765,189 | | |
Pharmaceuticals – 1.2% | | | | | | | | | | | | | |
Pfizer, Inc. | | | | | 903,095 | | | | | | 47,584,076 | | |
Takeda Pharmaceutical Co. Ltd. (Japan)(a) | | | | | 3,090 | | | | | | 44,681 | | |
Total Pharmaceuticals | | | | | | | | | | | 47,628,757 | | |
Software – 2.5% | | | | | | | | | | | | | |
Palantir Technologies, Inc., Class A* | | | | | 178,232 | | | | | | 2,443,561 | | |
UiPath, Inc., Class A* | | | | | 2,748,663 | | | | | | 100,408,659 | | |
Total Software | | | | | | | | | | | 102,852,220 | | |
Total Common Stocks (Cost $7,717,132,398) | | | | | | | | | | | 4,080,300,446 | | |
MONEY MARKET FUND – 0.0%(b) | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(c) (Cost $1,416,368) | | | | | 1,416,368 | | | | | | 1,416,368 | | |
Total Investments – 99.7% (Cost $7,718,548,766) | | | | | | | | | | | 4,081,716,814 | | |
Other Assets in Excess of Liabilities – 0.3% | | | | | | | | | | | 10,465,527 | | |
Net Assets – 100.0% | | | | | | | | | | $ | 4,092,182,341 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Genomic Revolution ETF
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Common Stocks – 21.6% | |
Biotechnology – 7.4% | |
AquaBounty Technologies, Inc. | |
32,699,225 | | | | | 3,768,776 | | | | | | (11,611,945) | | | | | | (15,572,311) | | | | | | (3,340,398) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Arcturus Therapeutics Holdings, Inc. | |
84,888,987 | | | | | 38,053,854 | | | | | | (46,295,335) | | | | | | 12,833,202 | | | | | | (25,120,532) | | | | | | — | | | | | | — | | | | | | 2,463,076 | | | | | | 64,360,176 | | |
CareDx, Inc. | |
310,172,395 | | | | | 89,533,944 | | | | | | (90,538,206) | | | | | | 3,080,418 | | | | | | (160,789,052) | | | | | | — | | | | | | — | | | | | | 3,623,433 | | | | | | 151,459,499 | | |
Cellectis SA | |
56,897,431 | | | | | 7,518,689 | | | | | | (24,736,585) | | | | | | (18,951,637) | | | | | | (2,728,772) | | | | | | — | | | | | | — | | | | | | 2,898,410 | | | | | | 17,999,126 | | |
Evogene Ltd. | |
9,030,619 | | | | | 1,260,274 | | | | | | (3,030,704) | | | | | | 203,793 | | | | | | (4,272,261) | | | | | | — | | | | | | — | | | | | | 2,296,202 | | | | | | 3,191,721 | | |
Fate Therapeutics, Inc. | |
357,383,678 | | | | | 130,458,732 | | | | | | (117,255,017) | | | | | | 1,725,707 | | | | | | (190,988,786) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Ionis Pharmaceuticals, Inc. | |
335,200,942 | | | | | 71,228,676 | | | | | | (136,074,277) | | | | | | (28,249,338) | | | | | | (18,940,917) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Repare Therapeutics, Inc. | |
93,387,201 | | | | | 38,264,433 | | | | | | (33,081,669) | | | | | | 22,546 | | | | | | (52,745,676) | | | | | | — | | | | | | — | | | | | | 2,971,279 | | | | | | 45,846,835 | | |
Surface Oncology, Inc. | |
26,008,455 | | | | | 21,592,501 | | | | | | (13,339,613) | | | | | | (934,252) | | | | | | (13,039,028) | | | | | | — | | | | | | — | | | | | | 5,410,150 | | | | | | 20,288,063 | | |
Twist Bioscience Corp. | |
303,792,362 | | | | | 44,686,884 | | | | | | (97,965,096) | | | | | | 8,559,051 | | | | | | (143,316,029) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Electronic Equipment, Instruments & Components – 1.2% | |
908 Devices, Inc. | |
81,883,531 | | | | | 49,899,974 | | | | | | (35,161,344) | | | | | | (1,415,556) | | | | | | (46,048,629) | | | | | | — | | | | | | — | | | | | | 3,107,331 | | | | | | 49,157,976 | | |
Financial Services – 0.6% | |
Dynamics Special Purpose Corp. | |
19,718,888 | | | | | 9,587,446 | | | | | | (6,086,431) | | | | | | 1,593 | | | | | | 87,242 | | | | | | — | | | | | | — | | | | | | 2,354,418 | | | | | | 23,308,738 | | |
Health Care Providers & Services – 5.2% | |
Accolade, Inc. | |
259,620,477 | | | | | 56,592,116 | | | | | | (73,772,398) | | | | | | (8,297,187) | | | | | | (138,393,944) | | | | | | — | | | | | | — | | | | | | 5,013,040 | | | | | | 95,749,064 | | |
Castle Biosciences, Inc. | |
156,646,658 | | | | | 19,315,415 | | | | | | (69,811,729) | | | | | | (21,224,277) | | | | | | (32,647,889) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Signify Health, Inc. | |
139,077,091 | | | | | 143,018,037 | | | | | | (60,583,184) | | | | | | (4,344,446) | | | | | | (101,763,449) | | | | | | — | | | | | | — | | | | | | 8,657,468 | | | | | | 115,404,049 | | |
Life Sciences Tools & Services – 7.2% | |
Berkeley Lights, Inc. | |
145,389,853 | | | | | 48,953,983 | | | | | | (33,763,469) | | | | | | (5,128,403) | | | | | | (121,228,292) | | | | | | — | | | | | | — | | | | | | 3,524,580 | | | | | | 34,223,672 | | |
Codexis, Inc. | |
135,791,147 | | | | | 28,063,739 | | | | | | (124,943,179) | | | | | | 26,562,833 | | | | | | 702,289 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Pacific Biosciences of California, Inc. | |
460,481,139 | | | | | 106,601,815 | | | | | | (138,790,335) | | | | | | 108,792,919 | | | | | | (391,443,969) | | | | | | — | | | | | | — | | | | | | 13,026,974 | | | | | | 145,641,569 | | |
Personalis, Inc. | |
97,468,702 | | | | | 47,361,263 | | | | | | (35,383,783) | | | | | | (2,443,664) | | | | | | (47,348,202) | | | | | | — | | | | | | — | | | | | | 5,237,429 | | | | | | 59,654,316 | | |
Quantum-Si, Inc. | |
71,309,635 | | | | | 70,230,761 | | | | | | (35,987,724) | | | | | | 72,530 | | | | | | (49,345,700) | | | | | | — | | | | | | — | | | | | | 11,749,374 | | | | | | 56,279,502 | | |
Molecular Diagnostics – 0.0% | |
CM Life Sciences II, Inc. | |
32,363,829 | | | | | 1,149,934 | | | | | | (1,108,561) | | | | | | (144,970) | | | | | | 5,547,068 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$3,209,212,245 | | | | $ | 1,027,141,246 | | | | | $ | (1,189,320,584) | | | | | $ | 55,148,551 | | | | | $ | (1,537,164,926) | | | | | $ | — | | | | | $ | — | | | | | | 72,333,164 | | | | | $ | 882,564,306 | | |
*
Non-income producing security
†
Affiliated security
(a)
American Depositary Receipt
(b)
Less than 0.05%
(c)
Rate shown represents annualized 7-day yield as of January 31, 2022.
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Genomic Revolution ETF
January 31, 2022 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Genomic Revolution ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 4,080,300,446 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,080,300,446 | | |
Money Market Fund | | | | | 1,416,368 | | | | | | — | | | | | | — | | | | | | 1,416,368 | | |
Total | | | | $ | 4,081,716,814 | | | | | $ | — | | | | | $ | — | | | | | $ | 4,081,716,814 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Autonomous Technology & Robotics ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 99.7% | | | | | | | | | | | | | |
Aerospace & Defense – 14.5% | | | | | | | | | | | | | |
AeroVironment, Inc.* | | | | | 837,787 | | | | | $ | 47,686,836 | | |
Archer Aviation, Inc., Class A*† | | | | | 8,355,720 | | | | | | 26,320,518 | | |
Elbit Systems Ltd. (Israel) | | | | | 183,083 | | | | | | 30,347,838 | | |
Kratos Defense & Security Solutions, Inc.*† | | | | | 7,020,820 | | | | | | 117,668,943 | | |
Lockheed Martin Corp. | | | | | 39,675 | | | | | | 15,438,733 | | |
Total Aerospace & Defense | | | | | | | | | | | 237,462,868 | | |
Airlines – 2.3% | | | | | | | | | | | | | |
Blade Air Mobility, Inc.*† | | | | | 6,106,734 | | | | | | 37,312,145 | | |
Auto Components – 2.7% | | | | | | | | | | | | | |
Magna International, Inc. (Canada) | | | | | 549,080 | | | | | | 44,261,339 | | |
Automobiles – 15.3% | | | | | | | | | | | | | |
BYD Co. Ltd. (China)(a) | | | | | 275,301 | | | | | | 16,405,187 | | |
Niu Technologies (China)*(a) | | | | | 2,848,560 | | | | | | 40,022,268 | | |
Tesla, Inc.* | | | | | 182,533 | | | | | | 170,982,312 | | |
XPeng, Inc. (China)*(a) | | | | | 683,183 | | | | | | 23,972,891 | | |
Total Automobiles | | | | | | | | | | | 251,382,658 | | |
Biotechnology – 0.0%(b) | | | | | | | | | | | | | |
Organovo Holdings, Inc.* | | | | | 104,918 | | | | | | 327,344 | | |
Diversified Consumer Services – 0.7% | | | | | | | | | | | | | |
2U, Inc.* | | | | | 731,542 | | | | | | 11,807,088 | | |
Diversified Telecommunication – 5.0% | | | | | | | | | | | | | |
Iridium Communications, Inc.* | | | | | 2,265,761 | | | | | | 81,295,504 | | |
Electronic Equipment, Instruments & Components – 8.6% | |
Teledyne Technologies, Inc.* | | | | | 50,372 | | | | | | 21,228,272 | | |
Trimble, Inc.* | | | | | 1,666,369 | | | | | | 120,245,187 | | |
Total Electronic Equipment, Instruments & Components | | | | | 141,473,459 | | |
Health Care Equipment & Services – 1.0% | |
Intuitive Surgical, Inc.* | | | | | 60,249 | | | | | | 17,121,561 | | |
Household Durables – 1.0% | | | | | | | | | | | | | |
Vuzix Corp.* | | | | | 2,520,443 | | | | | | 16,458,493 | | |
Interactive Media & Services – 3.9% | | | | | | | | | | | | | |
Alphabet, Inc., Class C* | | | | | 12,657 | | | | | | 34,350,718 | | |
Baidu, Inc. (China)*(a) | | | | | 182,662 | | | | | | 29,178,428 | | |
Total Interactive Media & Services | | | | | | | | | | | 63,529,146 | | |
Internet & Direct Marketing Retail – 0.0%(b) | |
JD.com, Inc. (China)*(a) | | | | | 1,267 | | | | | | 94,873 | | |
Machinery – 16.7% | | | | | | | | | | | | | |
Caterpillar, Inc. | | | | | 128,402 | | | | | | 25,880,707 | | |
Deere & Co. | | | | | 181,204 | | | | | | 68,205,186 | | |
Komatsu Ltd. (Japan)(a) | | | | | 3,023,475 | | | | | | 76,131,101 | | |
Markforged Holding Corp.*† | | | | | 9,705,167 | | | | | | 45,905,440 | | |
Proto Labs, Inc.* | | | | | 432,463 | | | | | | 21,700,993 | | |
Velo3D Inc.* | | | | | 5,538,325 | | | | | | 35,722,196 | | |
Total Machinery | | | | | | | | | | | 273,545,623 | | |
Road & Rail – 2.3% | | | | | | | | | | | | | |
TuSimple Holdings, Inc., Class A* | | | | | 1,984,162 | | | | | | 37,222,879 | | |
Semiconductors & Semiconductor Equipment – 1.8% | |
Teradyne, Inc. | | | | | 258,312 | | | | | | 30,333,578 | | |
Investments | | | Shares | | | Value | |
Software – 17.2% | | | | | | | | | | | | | |
ANSYS, Inc.* | | | | | 57,086 | | | | | $ | 19,409,811 | | |
Materialise NV (Belgium)*(a) | | | | | 1,184,459 | | | | | | 24,293,254 | | |
Palantir Technologies, Inc., Class A* | | | | | 2,479,038 | | | | | | 33,987,611 | | |
Synopsys, Inc.* | | | | | 58,197 | | | | | | 18,070,168 | | |
UiPath, Inc., Class A* | | | | | 3,642,039 | | | | | | 133,043,685 | | |
Unity Software, Inc.* | | | | | 510,621 | | | | | | 53,691,798 | | |
Total Software | | | | | | | | | | | 282,496,327 | | |
Technology Hardware, Storage & Peripherals – 6.7% | |
3D Systems Corp.* | | | | | 3,269,345 | | | | | | 58,521,275 | | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 7,796,486 | | | | | | 28,613,104 | | |
Stratasys Ltd.* | | | | | 935,351 | | | | | | 22,298,768 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 109,433,147 | | |
Total Common Stocks (Cost $2,203,854,604) | | | | | | | | | | | 1,635,558,032 | | |
MONEY MARKET FUND – 0.2% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(c) | | | | | | | | | | | | | |
(Cost $2,769,469) | | | | | 2,769,469 | | | | | | 2,769,469 | | |
Total Investments – 99.9% (Cost $2,206,624,073) | | | | | | | | | | | 1,638,327,501 | | |
Other Assets in Excess of Liabilities – 0.1% | | | | | | | | | | | 1,991,732 | | |
Net Assets – 100.0% | | | | | | | | | | $ | 1,640,319,233 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Autonomous Technology & Robotics ETF
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Common Stocks – 16.0% | | | | | | | | | |
Aerospace & Defense – 8.8% | |
Archer Aviation, Inc. | |
28,560,815 | | | | | 56,903,659 | | | | | | (14,463,027) | | | | | | (1,109,202) | | | | | | (43,571,727) | | | | | | — | | | | | | — | | | | | | 8,355,720 | | | | | | 26,320,518 | | |
Kratos Defense & Security Solutions, Inc. | |
192,932,864 | | | | | 56,243,438 | | | | | | (52,773,662) | | | | | | (4,856,570) | | | | | | (73,877,127) | | | | | | — | | | | | | — | | | | | | 7,020,820 | | | | | | 117,668,943 | | |
Airlines – 2.2% | |
Blade Air Mobility, Inc. | |
29,954,012 | | | | | 35,640,858 | | | | | | (15,015,159) | | | | | | 617,266 | | | | | | (13,884,832) | | | | | | — | | | | | | — | | | | | | 6,106,734 | | | | | | 37,312,145 | | |
Machinery – 5.0% | |
Markforged Holding Corp. | |
28,017,642 | | | | | 76,960,291 | | | | | | (17,561,969) | | | | | | (328,642) | | | | | | (41,181,882) | | | | | | — | | | | | | — | | | | | | 9,705,167 | | | | | | 45,905,440 | | |
Velo3D Inc. | |
26,430,752 | | | | | 41,939,406 | | | | | | (12,394,936) | | | | | | 592,243 | | | | | | (20,845,269) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$305,896,085 | | | | $ | 233,235,358 | | | | | $ | (102,076,926) | | | | | $ | (5,694,151) | | | | | $ | (171,358,490) | | | | | $ | — | | | | | $ | — | | | | | | 31,188,441 | | | | | $ | 227,207,046 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Less than 0.05%
(c)
Rate shown represents annualized 7-day yield as of January 31, 2022.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Autonomous Technology & Robotics ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 1,635,558,032 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,635,558,032 | | |
Money Market Fund | | | | | 2,769,469 | | | | | | — | | | | | | — | | | | | | 2,769,469 | | |
Total | | | | $ | 1,638,327,501 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,638,327,501 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 99.9% | | | | | | | | | | | | | |
Automobiles – 8.2% | | | | | | | | | | | | | |
Tesla, Inc.* | | | | | 1,139,789 | | | | | $ | 1,067,663,152 | | |
Biotechnology – 21.9% | | | | | | | | | | | | | |
Beam Therapeutics, Inc.*† | | | | | 6,060,272 | | | | | | 419,431,425 | | |
CRISPR Therapeutics AG (Switzerland)*† | | | | | 6,129,474 | | | | | | 390,753,968 | | |
Editas Medicine, Inc.* | | | | | 70,040 | | | | | | 1,333,562 | | |
Exact Sciences Corp.* | | | | | 8,025,361 | | | | | | 612,816,566 | | |
Fate Therapeutics, Inc.*† | | | | | 5,946,682 | | | | | | 246,846,770 | | |
Ginkgo Bioworks Holdings, Inc.* | | | | | 31,731,889 | | | | | | 189,756,696 | | |
Intellia Therapeutics, Inc.*† | | | | | 5,710,522 | | | | | | 540,044,066 | | |
Invitae Corp.*† | | | | | 17,416,439 | | | | | | 195,760,774 | | |
Iovance Biotherapeutics, Inc.* | | | | | 150 | | | | | | 2,497 | | |
Twist Bioscience Corp.* | | | | | 1,686,945 | | | | | | 100,238,272 | | |
Veracyte, Inc.*† | | | | | 4,722,315 | | | | | | 143,605,599 | | |
Total Biotechnology | | | | | | | | | | | 2,840,590,195 | | |
Capital Markets – 6.9% | | | | | | | | | | | | | |
Coinbase Global, Inc., Class A* | | | | | 3,457,191 | | | | | | 657,384,869 | | |
Robinhood Markets, Inc., Class A* | | | | | 16,469,317 | | | | | | 233,040,835 | | |
Total Capital Markets | | | | | | | | | | | 890,425,704 | | |
Diversified Consumer Services – 0.7% | |
2U, Inc.*† | | | | | 5,718,334 | | | | | | 92,293,911 | | |
Diversified Telecommunication – 1.4% | |
Iridium Communications, Inc.* | | | | | 5,023,494 | | | | | | 180,242,965 | | |
Electronic Equipment, Instruments & Components – 1.2% | |
Trimble, Inc.* | | | | | 2,066,649 | | | | | | 149,129,392 | | |
Entertainment – 11.3% | | | | | | | | | | | | | |
ROBLOX Corp., Class A* | | | | | 1,299,788 | | | | | | 85,604,038 | | |
Roku, Inc.* | | | | | 4,974,186 | | | | | | 816,015,213 | | |
Sea Ltd. (Taiwan)*(a) | | | | | 24,125 | | | | | | 3,626,229 | | |
Skillz, Inc.* | | | | | 3,384,567 | | | | | | 16,279,767 | | |
Spotify Technology SA* | | | | | 2,802,634 | | | | | | 550,044,949 | | |
Total Entertainment | | | | | | | | | | | 1,471,570,196 | | |
Health Care Equipment & Supplies – 0.4% | |
Cerus Corp.*† | | | | | 9,915,892 | | | | | | 53,149,181 | | |
Health Care Providers & Services – 1.1% | |
Signify Health, Inc., Class A*† | | | | | 11,121,843 | | | | | | 148,254,167 | | |
Health Care Technology – 6.5% | | | | | | | | | | | | | |
Teladoc Health, Inc.*† | | | | | 11,013,932 | | | | | | 844,878,724 | | |
Hotels Restaurants & Leisure – 2.4% | | | | | | | | | | | | | |
DraftKings, Inc., Class A* | | | | | 13,971,698 | | | | | | 308,634,809 | | |
Interactive Media & Services – 2.1% | | | | | | | | | | | | | |
Twitter, Inc.* | | | | | 7,422,233 | | | | | | 278,407,960 | | |
IT Services – 11.1% | | | | | | | | | | | | | |
Block, Inc.* | | | | | 4,067,790 | | | | | | 497,450,039 | | |
Shopify, Inc., Class A (Canada)* | | | | | 410,005 | | | | | | 395,343,221 | | |
Twilio, Inc., Class A* | | | | | 2,619,229 | | | | | | 539,875,482 | | |
Total IT Services | | | | | | | | | | | 1,432,668,742 | | |
Investments | | | Shares | | | Value | |
Life Sciences Tools & Services – 2.9% | | | | | | | | | | | | | |
10X Genomics, Inc., Class A* | | | | | 1,837,892 | | | | | $ | 176,933,863 | | |
Berkeley Lights, Inc.*† | | | | | 4,641,575 | | | | | | 45,069,693 | | |
Compugen Ltd. (Israel)*† | | | | | 5,682,802 | | | | | | 20,173,947 | | |
Pacific Biosciences of California, Inc.*† | | | | | 11,929,108 | | | | | | 133,367,428 | | |
Total Life Sciences Tools & Services | | | | | | | | | | | 375,544,931 | | |
Road & Rail – 1.0% | | | | | | | | | | | | | |
TuSimple Holdings, Inc., Class A* | | | | | 6,847,843 | | | | | | 128,465,534 | | |
Software – 19.9% | | | | | | | | | | | | | |
Materialise NV (Belgium)*†(a) | | | | | 3,772,337 | | | | | | 77,370,632 | | |
PagerDuty, Inc.*† | | | | | 7,299,320 | | | | | | 241,023,546 | | |
Palantir Technologies, Inc., Class A* | | | | | 24,474,907 | | | | | | 335,550,975 | | |
UiPath, Inc., Class A* | | | | | 14,129,740 | | | | | | 516,159,402 | | |
Unity Software, Inc.* | | | | | 5,433,778 | | | | | | 571,361,757 | | |
Zoom Video Communications, Inc., Class A* | | | | | 5,441,019 | | | | | | 839,440,411 | | |
Total Software | | | | | | | | | | | 2,580,906,723 | | |
Technology Hardware, Storage & Peripherals – 0.9% | |
3D Systems Corp.* | | | | | 75,333 | | | | | | 1,348,460 | | |
Stratasys Ltd.*† | | | | | 4,617,180 | | | | | | 110,073,571 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 111,422,031 | | |
Total Common Stocks (Cost $20,657,820,823) | | | | | | | | | | | 12,954,248,317 | | |
MONEY MARKET FUND – 0.1% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b) (Cost $17,592,362) | | | | | 17,592,362 | | | | | | 17,592,362 | | |
Total Investments – 100.0% (Cost $20,675,413,185) | | | | | | | | | | | 12,971,840,679 | | |
Liabilities in Excess of Other Assets – (0.0)%(c) | | | | | | | | | | | (3,561,337) | | |
Net Assets – 100.0% | | | | | | | | | | $ | 12,968,279,342 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Common Stocks – 28.5% | |
Biotechnology – 14.9% | |
Beam Therapeutics, Inc. | |
429,666,220 | | | | | 377,485,328 | | | | | | (259,713,176) | | | | | | 25,753,440 | | | | | | (153,760,387) | | | | | | — | | | | | | — | | | | | | 6,060,272 | | | | | | 419,431,425 | | |
CRISPR Therapeutics AG | |
590,141,202 | | | | | 395,738,354 | | | | | | (279,812,333) | | | | | | 54,615,163 | | | | | | (369,928,418) | | | | | | — | | | | | | — | | | | | | 6,129,474 | | | | | | 390,753,968 | | |
Editas Medicine, Inc. | |
179,157,870 | | | | | 60,448,693 | | | | | | (168,105,312) | | | | | | (22,191,880) | | | | | | (47,975,809) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Fate Therapeutics, Inc. | |
368,294,731 | | | | | 302,629,751 | | | | | | (188,518,666) | | | | | | (8,698,230) | | | | | | (226,860,816) | | | | | | — | | | | | | — | | | | | | 5,946,682 | | | | | | 246,846,770 | | |
Intellia Therapeutics, Inc. | |
588,966,306 | | | | | 503,715,195 | | | | | | (337,412,833) | | | | | | 265,862,472 | | | | | | (481,087,074) | | | | | | — | | | | | | — | | | | | | 5,710,522 | | | | | | 540,044,066 | | |
Invitae Corp. | |
331,826,516 | | | | | 314,351,089 | | | | | | (175,128,732) | | | | | | 39,254,286 | | | | | | (314,542,385) | | | | | | — | | | | | | — | | | | | | 17,416,439 | | | | | | 195,760,774 | | |
Iovance Biotherapeutics, Inc. | |
189,057,134 | | | | | 36,882,663 | | | | | | (203,368,496) | | | | | | (164,615,118) | | | | | | 142,046,314 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Veracyte, Inc. | |
146,417,966 | | | | | 150,829,544 | | | | | | (91,432,915) | | | | | | 24,676,740 | | | | | | (86,885,736) | | | | | | — | | | | | | — | | | | | | 4,722,315 | | | | | | 143,605,599 | | |
Diversified Consumer Services – 0.7% | |
2U, Inc. | |
223,797,134 | | | | | 87,329,285 | | | | | | (76,204,621) | | | | | | 13,435,801 | | | | | | (156,063,688) | | | | | | — | | | | | | — | | | | | | 5,718,334 | | | | | | 92,293,911 | | |
Diversified Telecommunication – 0.0% | |
Iridium Communications, Inc. | |
351,317,071 | | | | | 123,485,266 | | | | | | (256,202,296) | | | | | | (6,087,469) | | | | | | (32,269,607) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Health Care Equipment & Supplies – 0.4% | |
Cerus Corp. | |
61,502,127 | | | | | 22,020,315 | | | | | | (36,776,562) | | | | | | 2,330,886 | | | | | | 4,072,415 | | | | | | — | | | | | | — | | | | | | 9,915,892 | | | | | | 53,149,181 | | |
Health Care Providers & Services – 1.1% | |
Signify Health, Inc. | |
— | | | | | 321,243,136 | | | | | | (76,611,190) | | | | | | (1,173,170) | | | | | | (95,204,609) | | | | | | — | | | | | | — | | | | | | 11,121,843 | | | | | | 148,254,167 | | |
Health Care Technology – 6.5% | |
Teladoc Health, Inc. | |
1,309,104,544 | | | | | 867,940,252 | | | | | | (611,506,284) | | | | | | (11,819,785) | | | | | | (708,840,003) | | | | | | — | | | | | | — | | | | | | 11,013,932 | | | | | | 844,878,724 | | |
Life Sciences Tools & Services – 1.5% | |
Berkeley Lights, Inc. | |
158,277,143 | | | | | 90,104,092 | | | | | | (52,918,469) | | | | | | (1,994,950) | | | | | | (148,398,123) | | | | | | — | | | | | | — | | | | | | 4,641,575 | | | | | | 45,069,693 | | |
Compugen Ltd. | |
43,591,664 | | | | | 10,386,472 | | | | | | (16,207,883) | | | | | | 1,910,812 | | | | | | (19,507,118) | | | | | | — | | | | | | — | | | | | | 5,682,802 | | | | | | 20,173,947 | | |
Pacific Biosciences of California, Inc. | |
246,859,499 | | | | | 227,915,477 | | | | | | (124,140,933) | | | | | | 62,950,308 | | | | | | (280,216,923) | | | | | | — | | | | | | — | | | | | | 11,929,108 | | | | | | 133,367,428 | | |
Machinery – 0.0% | |
Proto Labs, Inc. | |
155,624,215 | | | | | 12,316,665 | | | | | | 150,882,022 | | | | | | (120,312,087) | | | | | | 103,253,229 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Software – 2.5% | |
Materialise NV | |
80,375,733 | | | | | 46,320,752 | | | | | | (43,500,051) | | | | | | 1,983,714 | | | | | | (7,809,516) | | | | | ��� | — | | | | | | — | | | | | | 3,772,337 | | | | | | 77,370,632 | | |
PagerDuty, Inc. | |
224,620,189 | | | | | 212,015,324 | | | | | | (140,437,856) | | | | | | 39,649,195 | | | | | | (94,823,306) | | | | | | — | | | | | | — | | | | | | 7,299,320 | | | | | | 241,023,546 | | |
Technology Hardware, Storage & Peripherals – 0.9% | |
Stratasys Ltd. | |
81,818,214 | | | | | 67,201,592 | | | | | | (55,780,223) | | | | | | 9,439,462 | | | | | | 7,394,526 | | | | | | — | | | | | | — | | | | | | 4,617,180 | | | | | | 110,073,571 | | |
$5,760,415,478 | | | | $ | 4,230,359,245 | | | | | $ | (3,042,896,809) | | | | | $ | 204,969,590 | | | | | $ | (2,967,407,034) | | | | | $ | — | | | | | $ | — | | | | | | 121,698,027 | | | | | $ | 3,702,097,402 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of January 31, 2022.
(c)
Less than 0.05%
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Innovation ETF
January 31, 2022 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 12,954,248,317 | | | | | $ | — | | | | | $ | — | | | | | $ | 12,954,248,317 | | |
Money Market Fund | | | | | 17,592,362 | | | | | | — | | | | | | — | | | | | | 17,592,362 | | |
Total | | | | $ | 12,971,840,679 | | | | | $ | — | | | | | $ | — | | | | | $ | 12,971,840,679 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Next Generation Internet ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 93.4% | | | | | | | | | | | | | |
Automobiles – 7.8% | | | | | | | | | | | | | |
Tesla, Inc.* | | | | | 223,908 | | | | | $ | 209,739,102 | | |
Banks – 0.5% | | | | | | | | | | | | | |
NU Holdings Ltd/Cayman Islands (Brazil)* | | | | | 1,684,776 | | | | | | 12,501,038 | | |
Biotechnology – 1.2% | | | | | | | | | | | | | |
Veracyte, Inc.* | | | | | 1,054,350 | | | | | | 32,062,783 | | |
Capital Markets – 10.2% | | | | | | | | | | | | | |
Coinbase Global, Inc., Class A* | | | | | 999,403 | | | | | | 190,036,481 | | |
Concord Acquisition Corp., Class A*† | | | | | 3,114,184 | | | | | | 30,986,131 | | |
Robinhood Markets, Inc., Class A* | | | | | 3,865,629 | | | | | | 54,698,650 | | |
Total Capital Markets | | | | | | | | | | | 275,721,262 | | |
Diversified Consumer Services – 0.7% | | | | | | | | | | | | | |
2U, Inc.* | | | | | 1,227,340 | | | | | | 19,809,268 | | |
Entertainment – 17.5% | | | | | | | | | | | | | |
Endeavor Group Holdings, Inc., Class A* | | | | | 497,509 | | | | | | 15,606,857 | | |
ROBLOX Corp., Class A* | | | | | 1,194,424 | | | | | | 78,664,765 | | |
Roku, Inc.* | | | | | 957,906 | | | | | | 157,144,479 | | |
Sea Ltd. (Taiwan)*(a) | | | | | 332,817 | | | | | | 50,025,723 | | |
Skillz, Inc.* | | | | | 1,381,349 | | | | | | 6,644,289 | | |
Spotify Technology SA* | | | | | 684,386 | | | | | | 134,317,596 | | |
Walt Disney Co. (The)* | | | | | 198,213 | | | | | | 28,338,513 | | |
Total Entertainment | | | | | | | | | | | 470,742,222 | | |
Health Care Technology – 5.4% | | | | | | | | | | | | | |
Teladoc Health, Inc.* | | | | | 1,901,573 | | | | | | 145,869,665 | | |
Hotels Restaurants & Leisure – 3.3% | | | | | | | | | | | | | |
DraftKings, Inc., Class A* | | | | | 3,975,960 | | | | | | 87,828,956 | | |
Household Durables – 1.1% | | | | | | | | | | | | | |
Vuzix Corp.*† | | | | | 4,452,066 | | | | | | 29,071,991 | | |
Interactive Media & Services – 7.0% | | | | | | | | | | | | | |
Genius Sports Ltd (United Kingdom)* | | | | | 5,534,564 | | | | | | 35,863,975 | | |
Nextdoor Holdings, Inc.*† | | | | | 4,305,133 | | | | | | 24,367,053 | | |
Snap, Inc., Class A* | | | | | 1,160 | | | | | | 37,746 | | |
Twitter, Inc.* | | | | | 3,420,518 | | | | | | 128,303,630 | | |
Total Interactive Media & Services | | | | | | | | | | | 188,572,404 | | |
Internet & Direct Marketing Retail – 2.3% | |
Etsy, Inc.* | | | | | 180,131 | | | | | | 28,294,978 | | |
MercadoLibre, Inc. (Argentina)* | | | | | 31,049 | | | | | | 35,149,331 | | |
Total Internet & Direct Marketing Retail | | | | | | | | | | | 63,444,309 | | |
IT Services – 15.4% | | | | | | | | | | | | | |
Adyen NV (Netherlands)*(a) | | | | | 1,213,882 | | | | | | 24,666,082 | | |
Block, Inc.* | | | | | 793,485 | | | | | | 97,035,281 | | |
Cloudflare, Inc., Class A* | | | | | 345,169 | | | | | | 33,274,291 | | |
Okta, Inc.* | | | | | 145,811 | | | | | | 28,854,539 | | |
Shopify, Inc., Class A (Canada)* | | | | | 107,162 | | | | | | 103,329,887 | | |
Snowflake, Inc., Class A* | | | | | 91 | | | | | | 25,107 | | |
Twilio, Inc., Class A* | | | | | 618,843 | | | | | | 127,555,919 | | |
Total IT Services | | | | | | | | | | | 414,741,106 | | |
Investments | | | Shares | | | Value | |
Leisure Products – 0.0%(b) | | | | | | | | | | | | | |
Peloton Interactive, Inc., Class A* | | | | | 9,044 | | | | | $ | 247,173 | | |
Software – 19.9% | | | | | | | | | | | | | |
DocuSign, Inc.* | | | | | 345 | | | | | | 43,391 | | |
LivePerson, Inc.* | | | | | 94 | | | | | | 2,808 | | |
Monday.com Ltd.* | | | | | 60,848 | | | | | | 12,736,703 | | |
PagerDuty, Inc.* | | | | | 1,592,165 | | | | | | 52,573,288 | | |
Palantir Technologies, Inc., Class A* | | | | | 2,980,991 | | | | | | 40,869,387 | | |
Splunk, Inc.* | | | | | 779,656 | | | | | | 96,614,971 | | |
UiPath, Inc., Class A* | | | | | 2,295,672 | | | | | | 83,860,898 | | |
Unity Software, Inc.* | | | | | 889,544 | | | | | | 93,535,552 | | |
Zoom Video Communications, Inc., Class A* | | | | | 1,004,325 | | | | | | 154,947,261 | | |
Total Software | | | | | | | | | | | 535,184,259 | | |
Technology Hardware, Storage & Peripherals – 1.1% | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 8,122,636 | | | | | | 29,810,074 | | |
Total Common Stocks (Cost $4,031,424,693) | | | | | | | | | | | 2,515,345,612 | | |
UNIT TRUST – 6.2% | | | | | | | | | | | | | |
Financials – 6.2% | | | | | | | | | | | | | |
Grayscale Bitcoin Trust BTC* (Cost $239,469,341) | | | | | 6,387,460 | | | | | | 167,606,950 | | |
MONEY MARKET FUND – 0.1% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(c) (Cost $1,799,225) | | | | | 1,799,225 | | | | | | 1,799,225 | | |
Total Investments – 99.7% (Cost $4,272,693,259) | | | | | | | | | | | 2,684,751,787 | | |
Other Assets in Excess of Liabilities – 0.3% | | | | | | | | | | | 7,940,057 | | |
Net Assets – 100.0% | | | | | | | | | | $ | 2,692,691,844 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Next Generation Internet ETF
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Common Stocks – 3.1% | | | | | | | | | |
Capital Markets – 1.1% | |
Concord Acquisition Corp. | |
28,340,692 | | | | | 18,772,935 | | | | | | (15,018,160) | | | | | | 121,190 | | | | | | (1,230,526) | | | | | | — | | | | | | — | | | | | | 3,114,184 | | | | | | 30,986,131 | | |
Household Durables – 1.1% | |
Vuzix Corp. | |
59,763,791 | | | | | 31,634,114 | | | | | | (23,101,707) | | | | | | (3,459,216) | | | | | | (35,764,991) | | | | | | — | | | | | | — | | | | | | 4,452,066 | | | | | | 29,071,991 | | |
Interactive Media & Services – 0.9% | |
Nextdoor Holdings, Inc. | |
44,079,858 | | | | | 20,834,690 | | | | | | (18,987,284) | | | | | | (976,414) | | | | | | (20,583,797) | | | | | | — | | | | | | — | | | | | | 4,305,133 | | | | | | 24,367,053 | | |
$132,184,341 | | | | $ | 71,241,739 | | | | | $ | (57,107,151) | | | | | $ | (4,314,440) | | | | | $ | (57,579,314) | | | | | $ | — | | | | | $ | — | | | | | | 11,871,383 | | | | | $ | 84,425,175 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Less than 0.05%
(c)
Rate shown represents annualized 7-day yield as of January 31, 2022.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Next Generation Internet ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 2,515,345,612 | | | | | $ | — | | | | | $ | — | | | | | $ | 2,515,345,612 | | |
Unit Trust‡ | | | | | 167,606,950 | | | | | | — | | | | | | — | | | | | | 167,606,950 | | |
Money Market Fund | | | | | 1,799,225 | | | | | | — | | | | | | — | | | | | | 1,799,225 | | |
Total | | | | $ | 2,684,751,787 | | | | | $ | — | | | | | $ | — | | | | | $ | 2,684,751,787 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Fintech Innovation ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 98.9% | | | | | | | | | | | | | |
Banks – 6.7% | | | | | | | | | | | | | |
NU Holdings Ltd, Class A (Brazil)* | | | | | 1,842,995 | | | | | $ | 13,675,023 | | |
Silvergate Capital Corp., Class A* | | | | | 450,471 | | | | | | 48,533,745 | | |
TCS Group Holding PLC, Class Reg S (Russia)(a) | | | | | 622,108 | | | | | | 44,294,090 | | |
Total Banks | | | | | | | | | | | 106,502,858 | | |
Capital Markets – 14.0% | | | | | | | | | | | | | |
Coinbase Global, Inc., Class A* | | | | | 749,657 | | | | | | 142,547,279 | | |
Concord Acquisition Corp., Class A* | | | | | 68,331 | | | | | | 679,893 | | |
Intercontinental Exchange, Inc. | | | | | 134,368 | | | | | | 17,019,051 | | |
Robinhood Markets, Inc., Class A* | | | | | 4,550,966 | | | | | | 64,396,169 | | |
Total Capital Markets | | | | | | | | | | | 224,642,392 | | |
Consumer Finance – 2.9% | | | | | | | | | | | | | |
Kaspi.KZ JSC (Kazakhstan)(a) | | | | | 200,628 | | | | | | 17,053,380 | | |
LendingClub Corp.* | | | | | 1,525,069 | | | | | | 28,610,294 | | |
Total Consumer Finance | | | | | | | | | | | 45,663,674 | | |
Entertainment – 4.5% | | | | | | | | | | | | | |
Sea Ltd. (Taiwan)*(b) | | | | | 477,069 | | | | | | 71,708,241 | | |
Health Care Technology – 4.0% | | | | | | | | | | | | | |
Teladoc Health, Inc.* | | | | | 835,943 | | | | | | 64,125,188 | | |
Hotels Restaurants & Leisure – 3.0% | | | | | | | | | | | | | |
DraftKings, Inc., Class A* | | | | | 2,196,942 | | | | | | 48,530,449 | | |
Insurance – 3.6% | | | | | | | | | | | | | |
Discovery Ltd. (South Africa)* | | | | | 5,614,722 | | | | | | 56,833,991 | | |
Interactive Media & Services – 2.4% | | | | | | | | | | | | | |
Snap, Inc., Class A* | | | | | 9,195 | | | | | | 299,205 | | |
Twitter, Inc.* | | | | | 458,009 | | | | | | 17,179,917 | | |
Z Holdings Corp. (Japan) | | | | | 4,305,184 | | | | | | 21,589,518 | | |
Total Interactive Media & Services | | | | | | | | | | | 39,068,640 | | |
Internet & Direct Marketing Retail – 8.8% | |
Etsy, Inc.* | | | | | 203,755 | | | | | | 32,005,836 | | |
Farfetch Ltd., Class A (United Kingdom)* | | | | | 695,363 | | | | | | 15,096,331 | | |
Global-e Online Ltd. (Israel)* | | | | | 110,862 | | | | | | 3,958,882 | | |
JD.com, Inc. (China)*(b) | | | | | 337,056 | | | | | | 25,238,753 | | |
MercadoLibre, Inc. (Argentina)* | | | | | 57,505 | | | | | | 65,099,110 | | |
Pinduoduo, Inc. (China)*(b) | | | | | 282 | | | | | | 16,875 | | |
Total Internet & Direct Marketing Retail | | | | | | | | | | | 141,415,787 | | |
IT Services – 33.9% | | | | | | | | | | | | | |
Adyen NV (Netherlands)*(c) | | | | | 28,465 | | | | | | 57,210,135 | | |
Block, Inc.* | | | | | 1,251,071 | | | | | | 152,993,473 | | |
PayPal Holdings, Inc.* | | | | | 159,834 | | | | | | 27,481,858 | | |
Shopify, Inc., Class A (Canada)* | | | | | 134,358 | | | | | | 129,553,358 | | |
StoneCo Ltd., Class A (Brazil)* | | | | | 2,519,552 | | | | | | 39,254,620 | | |
Toast, Inc., Class A* | | | | | 1,240,007 | | | | | | 28,371,360 | | |
Twilio, Inc., Class A* | | | | | 523,986 | | | | | | 108,003,994 | | |
Total IT Services | | | | | | | | | | | 542,868,798 | | |
Investments | | | Shares | | | Value | |
Real Estate Management & Development – 3.9% | |
Opendoor Technologies, Inc.* | | | | | 1,474,855 | | | | | $ | 14,645,310 | | |
Zillow Group, Inc., Class C* | | | | | 933,251 | | | | | | 47,110,511 | | |
Total Real Estate Management & Development | | | | | | | | | | | 61,755,821 | | |
Software – 11.2% | | | | | | | | | | | | | |
Bill.com Holdings, Inc.* | | | | | 148,481 | | | | | | 27,945,609 | | |
DocuSign, Inc.* | | | | | 150,797 | | | | | | 18,965,739 | | |
Intuit, Inc. | | | | | 35,561 | | | | | | 19,744,534 | | |
Palantir Technologies, Inc., Class A* | | | | | 83,330 | | | | | | 1,142,454 | | |
UiPath, Inc., Class A* | | | | | 2,289,059 | | | | | | 83,619,325 | | |
Workday, Inc., Class A* | | | | | 112,388 | | | | | | 28,435,288 | | |
Total Software | | | | | | | | | | | 179,852,949 | | |
Total Common Stocks (Cost $2,408,502,695) | | | | | | | | | | | 1,582,968,788 | | |
MONEY MARKET FUND – 0.1% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(d) (Cost $2,308,378) | | | | | 2,308,378 | | | | | | 2,308,378 | | |
Total Investments – 99.0% (Cost $2,410,811,073) | | | | | | | | | | | 1,585,277,166 | | |
Other Assets in Excess of Liabilities – 1.0% | | | | | | | | | | | 16,781,994 | | |
Net Assets – 100.0% | | | | | | | | | | $ | 1,602,059,160 | | |
*
Non-income producing security
(a)
Global Depositary Receipt
(b)
American Depositary Receipt
(c)
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
(d)
Rate shown represents annualized 7-day yield as of January 31, 2022.
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Fintech Innovation ETF
January 31, 2022 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Fintech Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 1,582,968,788 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,582,968,788 | | |
Money Market Fund | | | | | 2,308,378 | | | | | | — | | | | | | — | | | | | | 2,308,378 | | |
Total | | | | $ | 1,585,277,166 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,585,277,166 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Space Exploration & Innovation ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 91.7% | | | | | | | | | | | | | |
Aerospace & Defense – 29.8% | | | | | | | | | | | | | |
AeroVironment, Inc.* | | | | | 284,852 | | | | | $ | 16,213,776 | | |
Airbus SE (France)* | | | | | 36,462 | | | | | | 4,592,773 | | |
Archer Aviation, Inc., Class A* | | | | | 1,792,949 | | | | | | 5,647,789 | | |
Elbit Systems Ltd. (Israel) | | | | | 37,947 | | | | | | 6,290,095 | | |
HEICO Corp. | | | | | 35,570 | | | | | | 4,851,392 | | |
Kratos Defense & Security Solutions, Inc.* | | | | | 1,707,289 | | | | | | 28,614,164 | | |
L3Harris Technologies, Inc. | | | | | 108,274 | | | | | | 22,660,666 | | |
Lockheed Martin Corp. | | | | | 15,561 | | | | | | 6,055,252 | | |
Mynaric AG (Germany)*(a) | | | | | 439,508 | | | | | | 4,847,773 | | |
Spirit AeroSystems Holdings, Inc., Class A | | | | | 188,776 | | | | | | 8,274,052 | | |
Thales SA (France) | | | | | 52,781 | | | | | | 4,829,107 | | |
Total Aerospace & Defense | | | | | | | | | | | 112,876,839 | | |
Air Freight & Logistics – 3.5% | | | | | | | | | | | | | |
JD Logistics, Inc. (China)*(b) | | | | | 4,496,326 | | | | | | 13,349,914 | | |
Airlines – 4.0% | | | | | | | | | | | | | |
Blade Air Mobility, Inc.* | | | | | 1,772,095 | | | | | | 10,827,501 | | |
Joby Aviation, Inc.* | | | | | 1,004,527 | | | | | | 4,168,787 | | |
Total Airlines | | | | | | | | | | | 14,996,288 | | |
Diversified Telecommunication – 6.0% | | | | | | | | | | | | | |
Iridium Communications, Inc.* | | | | | 634,460 | | | | | | 22,764,425 | | |
Electronic Equipment, Instruments & Components – 10.7% | |
Teledyne Technologies, Inc.* | | | | | 9,446 | | | | | | 3,980,828 | | |
Trimble, Inc.* | | | | | 509,525 | | | | | | 36,767,324 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 40,748,152 | | |
Entertainment – 0.0%(c) | | | | | | | | | | | | | |
Netflix, Inc.* | | | | | 103 | | | | | | 43,995 | | |
Household Durables – 2.5% | | | | | | | | | | | | | |
Garmin Ltd. | | | | | 75,871 | | | | | | 9,439,870 | | |
Industrial Conglomerates – 1.3% | | | | | | | | | | | | | |
Honeywell International, Inc. | | | | | 24,115 | | | | | | 4,931,035 | | |
Interactive Media & Services – 2.0% | | | | | | | | | | | | | |
Alphabet, Inc., Class C* | | | | | 2,863 | | | | | | 7,770,096 | | |
Internet & Direct Marketing Retail – 3.1% | | | | | | | | | | | | | |
Amazon.com, Inc.* | | | | | 3,967 | | | | | | 11,867,161 | | |
Machinery – 13.1% | | | | | | | | | | | | | |
Deere & Co. | | | | | 27,470 | | | | | | 10,339,708 | | |
Komatsu Ltd. (Japan) | | | | | 859,488 | | | | | | 20,956,929 | | |
Markforged Holding Corp.* | | | | | 1,847,629 | | | | | | 8,739,285 | | |
Velo3D Inc.* | | | | | 1,467,254 | | | | | | 9,463,788 | | |
Total Machinery | | | | | | | | | | | 49,499,710 | | |
Semiconductors & Semiconductor Equipment – 1.4% | |
Teradyne, Inc. | | | | | 45,063 | | | | | | 5,291,748 | | |
Software – 13.3% | | | | | | | | | | | | | |
ANSYS, Inc.* | | | | | 12,090 | | | | | | 4,110,721 | | |
Dassault Systemes SE (France) | | | | | 251,973 | | | | | | 12,016,642 | | |
Palantir Technologies, Inc., Class A* | | | | | 477,453 | | | | | | 6,545,881 | | |
Synopsys, Inc.* | | | | | 12,759 | | | | | | 3,961,669 | | |
UiPath, Inc., Class A* | | | | | 351,351 | | | | | | 12,834,852 | | |
Unity Software, Inc.* | | | | | 104,051 | | | | | | 10,940,963 | | |
Total Software | | | | | | | | | | | 50,410,728 | | |
Investments | | | Shares | | | Value | |
Technology Hardware, Storage & Peripherals – 1.0% | |
3D Systems Corp.* | | | | | 216,277 | | | | | $ | 3,871,358 | | |
Total Common Stocks (Cost $436,509,965) | | | | | | | | | | | 347,861,319 | | |
EXCHANGE-TRADED FUND – 7.9% | | | | | | | | | | | | | |
Equity Fund – 7.9% | | | | | | | | | | | | | |
The 3D Printing ETF† (Cost $38,824,372) | | | | | 987,008 | | | | | | 29,797,772 | | |
MONEY MARKET FUND – 0.1% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(d) (Cost $283,896) | | | | | 283,896 | | | | | | 283,896 | | |
Total Investments – 99.7% (Cost $475,618,233) | | | | | | | | | | | 377,942,987 | | |
Other Assets in Excess of Liabilities – 0.3% | | | | | | | | | | | 1,311,379 | | |
Net Assets – 100.0% | | | | | | | | | | $ | 379,254,366 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Space Exploration & Innovation ETF
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Exchange-Traded Fund – 7.9% | | | | | | | | | |
Equity Fund – 7.9% | | | | | | | | | |
The 3D Printing ETF | |
41,642,604 | | | | | 6,315,301 | | | | | | (9,763,808) | | | | | | (566,410) | | | | | | (7,829,915) | | | | | | 604 | | | | | | — | | | | | | 987,008 | | | | | | 29,797,772 | | |
$41,642,604 | | | | $ | 6,315,301 | | | | | $ | (9,763,808) | | | | | $ | (566,410) | | | | | $ | (7,829,915) | | | | | $ | 604 | | | | | $ | — | | | | | | 987,008 | | | | | $ | 29,797,772 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
(c)
Less than 0.05%
(d)
Rate shown represents annualized 7-day yield as of January 31, 2022.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Space Exploration & Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 347,861,319 | | | | | $ | — | | | | | $ | — | | | | | $ | 347,861,319 | | |
Exchange-Traded Fund | | | | | 29,797,772 | | | | | | — | | | | | | — | | | | | | 29,797,772 | | |
Money Market Fund | | | | | 283,896 | | | | | | — | | | | | | — | | | | | | 283,896 | | |
Total | | | | $ | 377,942,987 | | | | | $ | — | | | | | $ | — | | | | | $ | 377,942,987 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 99.7% | | | | | | | | | | | | | |
Aerospace & Defense – 2.1% | | | | | | | | | | | | | |
AeroVironment, Inc.* | | | | | 3,460 | | | | | $ | 196,943 | | |
Axon Enterprise, Inc.* | | | | | 1,387 | | | | | | 194,083 | | |
Total Aerospace & Defense | | | | | | | | | | | 391,026 | | |
Auto Components – 1.1% | | | | | | | | | | | | | |
Autoliv, Inc. (Sweden) | | | | | 2,085 | | | | | | 206,498 | | |
Automobiles – 1.0% | | | | | | | | | | | | | |
Tesla, Inc.* | | | | | 202 | | | | | | 189,217 | | |
Biotechnology – 2.8% | | | | | | | | | | | | | |
Abcam PLC (United Kingdom)*(a) | | | | | 9,127 | | | | | | 163,464 | | |
CareDx, Inc.* | | | | | 4,702 | | | | | | 196,544 | | |
Twist Bioscience Corp.* | | | | | 2,762 | | | | | | 164,118 | | |
Total Biotechnology | | | | | | | | | | | 524,126 | | |
Capital Markets – 1.1% | | | | | | | | | | | | | |
Cboe Global Markets, Inc. | | | | | 1,655 | | | | | | 196,167 | | |
Commercial Services & Supplies – 2.3% | | | | | | | | | | | | | |
Brady Corp., Class A | | | | | 3,997 | | | | | | 207,524 | | |
Steelcase, Inc., Class A | | | | | 18,363 | | | | | | 226,600 | | |
Total Commercial Services & Supplies | | | | | | | | | | | 434,124 | | |
Communications Equipment – 0.9% | | | | | | | | | | | | | |
Radware Ltd. (Israel)* | | | | | 5,158 | | | | | | 173,464 | | |
Construction Materials – 1.1% | | | | | | | | | | | | | |
CRH PLC (Ireland)(a) | | | | | 4,091 | | | | | | 206,227 | | |
Containers & Packaging – 1.1% | | | | | | | | | | | | | |
Sonoco Products Co. | | | | | 3,723 | | | | | | 210,871 | | |
Diversified Consumer Services – 0.9% | | | | | | | | | | | | | |
2U, Inc.* | | | | | 10,550 | | | | | | 170,277 | | |
Electrical Equipment – 1.8% | | | | | | | | | | | | | |
ChargePoint Holdings, Inc.* | | | | | 11,254 | | | | | | 155,868 | | |
TPI Composites, Inc.* | | | | | 14,229 | | | | | | 171,744 | | |
Total Electrical Equipment | | | | | | | | | | | 327,612 | | |
Electronic Equipment, Instruments & Components – 2.1% | |
CDW Corp. | | | | | 1,051 | | | | | | 198,692 | | |
Knowles Corp.* | | | | | 9,219 | | | | | | 195,535 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 394,227 | | |
Entertainment – 3.3% | | | | | | | | | | | | | |
Netflix, Inc.* | | | | | 356 | | | | | | 152,062 | | |
ROBLOX Corp., Class A* | | | | | 2,074 | | | | | | 136,594 | | |
Roku, Inc.* | | | | | 930 | | | | | | 152,566 | | |
Spotify Technology SA* | | | | | 915 | | | | | | 179,578 | | |
Total Entertainment | | | | | | | | | | | 620,800 | | |
Food Products – 2.4% | | | | | | | | | | | | | |
Beyond Meat, Inc.* | | | | | 3,258 | | | | | | 212,193 | | |
McCormick & Co., Inc. | | | | | 2,238 | | | | | | 224,494 | | |
Total Food Products | | | | | | | | | | | 436,687 | | |
Health Care Technology – 1.9% | | | | | | | | | | | | | |
Omnicell, Inc.* | | | | | 1,194 | | | | | | 179,267 | | |
Teladoc Health, Inc.* | | | | | 2,327 | | | | | | 178,504 | | |
Total Health Care Technology | | | | | | | | | | | 357,771 | | |
Hotels, Restaurants & Leisure – 1.0% | | | | | | | | | | | | | |
Starbucks Corp. | | | | | 1,839 | | | | | | 180,811 | | |
Household Durables – 4.2% | | | | | | | | | | | | | |
Garmin Ltd. | | | | | 1,579 | | | | | | 196,459 | | |
iRobot Corp.* | | | | | 3,241 | | | | | | 212,351 | | |
Sonos, Inc.* | | | | | 7,244 | | | | | | 182,694 | | |
Sony Group Corp. (Japan)(a) | | | | | 1,705 | | | | | | 190,380 | | |
Total Household Durables | | | | | | | | | | | 781,884 | | |
Investments | | | Shares | | | Value | |
Household Products – 1.0% | | | | | | | | | | | | | |
Spectrum Brands Holdings, Inc. | | | | | 2,136 | | | | | $ | 190,916 | | |
Industrial Conglomerates – 1.0% | | | | | | | | | | | | | |
Roper Technologies, Inc. | | | | | 436 | | | | | | 190,602 | | |
Insurance – 0.9% | | | | | | | | | | | | | |
Lemonade, Inc.* | | | | | 5,071 | | | | | | 161,917 | | |
Interactive Media & Services – 1.2% | | | | | | | | | | | | | |
TripAdvisor, Inc.* | | | | | 7,858 | | | | | | 213,345 | | |
Internet & Direct Marketing Retail – 4.1% | | | | | | | | | | | | | |
Amazon.com, Inc.* | | | | | 63 | | | | | | 188,463 | | |
Fiverr International Ltd.* | | | | | 1,876 | | | | | | 160,041 | | |
JD.com, Inc. (China)*(a) | | | | | 3,059 | | | | | | 229,058 | | |
Stitch Fix, Inc., Class A* | | | | | 11,252 | | | | | | 184,870 | | |
Total Internet & Direct Marketing Retail | | | | | | | | | | | 762,432 | | |
IT Services – 6.1% | | | | | | | | | | | | | |
Adyen NV (Netherlands)*(a) | | | | | 8,213 | | | | | | 166,888 | | |
Cloudflare, Inc., Class A* | | | | | 1,623 | | | | | | 156,457 | | |
DigitalOcean Holdings, Inc.* | | | | | 2,634 | | | | | | 151,034 | | |
Globant SA* | | | | | 683 | | | | | | 174,288 | | |
Shopify, Inc., Class A (Canada)* | | | | | 155 | | | | | | 149,457 | | |
Snowflake, Inc., Class A* | | | | | 627 | | | | | | 172,989 | | |
Twilio, Inc., Class A* | | | | | 809 | | | | | | 166,751 | | |
Total IT Services | | | | | | | | | | | 1,137,864 | | |
Leisure Products – 2.1% | | | | | | | | | | | | | |
Acushnet Holdings Corp. | | | | | 4,034 | | | | | | 188,388 | | |
Hasbro, Inc. | | | | | 2,120 | | | | | | 196,057 | | |
Total Leisure Products | | | | | | | | | | | 384,445 | | |
Life Sciences Tools & Services – 2.8% | | | | | | | | | | | | | |
Bio-Techne Corp. | | | | | 412 | | | | | | 155,081 | | |
Bruker Corp. | | | | | 2,549 | | | | | | 169,763 | | |
Thermo Fisher Scientific, Inc. | | | | | 320 | | | | | | 186,016 | | |
Total Life Sciences Tools & Services | | | | | | | | | | | 510,860 | | |
Machinery – 1.1% | | | | | | | | | | | | | |
Proto Labs, Inc.* | | | | | 4,151 | | | | | | 208,297 | | |
Media – 2.3% | | | | | | | | | | | | | |
Cardlytics, Inc.* | | | | | 3,176 | | | | | | 213,110 | | |
Pearson PLC (United Kingdom)(a) | | | | | 25,682 | | | | | | 218,297 | | |
Total Media | | | | | | | | | | | 431,407 | | |
Personal Products – 1.1% | | | | | | | | | | | | | |
Natura & Co. Holding SA (Brazil)*(a) | | | | | 23,198 | | | | | | 200,895 | | |
Semiconductors & Semiconductor Equipment – 5.8% | |
ASML Holding NV (Netherlands) | | | | | 270 | | | | | | 182,844 | | |
Canadian Solar, Inc. (Canada)* | | | | | 6,801 | | | | | | 190,360 | | |
MaxLinear, Inc., Class A* | | | | | 2,864 | | | | | | 171,897 | | |
NVIDIA Corp. | | | | | 731 | | | | | | 178,993 | | |
Skyworks Solutions, Inc. | | | | | 1,381 | | | | | | 202,344 | | |
Teradyne, Inc. | | | | | 1,310 | | | | | | 153,833 | | |
Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 1,080,271 | | |
Software – 25.6% | | | | | | | | | | | | | |
Adobe, Inc.* | | | | | 379 | | | | | | 202,500 | | |
Agora, Inc. (China)*(a) | | | | | 12,895 | | | | | | 147,390 | | |
Atlassian Corp. PLC, Class A* | | | | | 559 | | | | | | 181,306 | | |
Autodesk, Inc.* | | | | | 759 | | | | | | 189,591 | | |
Bill.Com Holdings, Inc.* | | | | | 855 | | | | | | 160,920 | | |
Crowdstrike Holdings, Inc., Class A* | | | | | 1,043 | | | | | | 188,407 | | |
Datadog, Inc., Class A* | | | | | 1,207 | | | | | | 176,355 | | |
DocuSign, Inc.* | | | | | 1,403 | | | | | | 176,455 | | |
Dropbox, Inc., Class A* | | | | | 8,742 | | | | | | 216,364 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
Dynatrace, Inc.* | | | | | 3,536 | | | | | $ | 193,985 | | |
Elastic NV* | | | | | 1,734 | | | | | | 161,695 | | |
Five9, Inc.* | | | | | 1,570 | | | | | | 197,349 | | |
Gitlab, Inc., Class A* | | | | | 2,520 | | | | | | 161,305 | | |
HubSpot, Inc.* | | | | | 322 | | | | | | 157,394 | | |
Intuit, Inc. | | | | | 333 | | | | | | 184,892 | | |
Momentive Global, Inc.* | | | | | 10,053 | | | | | | 172,208 | | |
Nutanix, Inc., Class A* | | | | | 6,748 | | | | | | 184,490 | | |
PagerDuty, Inc.* | | | | | 6,169 | | | | | | 203,700 | | |
Qualys, Inc.* | | | | | 1,553 | | | | | | 199,001 | | |
Rapid7, Inc.* | | | | | 1,829 | | | | | | 176,188 | | |
salesforce.com, Inc.* | | | | | 844 | | | | | | 196,340 | | |
Splunk, Inc.* | | | | | 1,872 | | | | | | 231,978 | | |
Sprout Social, Inc., Class A* | | | | | 2,344 | | | | | | 161,384 | | |
Synopsys, Inc.* | | | | | 582 | | | | | | 180,711 | | |
Unity Software, Inc.* | | | | | 1,499 | | | | | | 157,620 | | |
Workday, Inc., Class A* | | | | | 785 | | | | | | 198,613 | | |
Total Software | | | | | | | | | | | 4,758,141 | | |
Specialty Retail – 4.1% | | | | | | | | | | | | | |
Best Buy Co., Inc. | | | | | 2,113 | | | | | | 209,779 | | |
Buckle, Inc. (The) | | | | | 5,115 | | | | | | 192,528 | | |
Hibbett, Inc. | | | | | 2,995 | | | | | | 184,642 | | |
Warby Parker, Inc., Class A* | | | | | 4,589 | | | | | | 170,573 | | |
Total Specialty Retail | | | | | | | | | | | 757,522 | | |
Technology Hardware, Storage & Peripherals – 4.4% | |
Apple, Inc. | | | | | 1,214 | | | | | | 212,183 | | |
Corsair Gaming, Inc.* | | | | | 10,165 | | | | | | 198,624 | | |
HP, Inc. | | | | | 5,713 | | | | | | 209,839 | | |
NetApp, Inc. | | | | | 2,345 | | | | | | 202,866 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 823,512 | | |
Textiles, Apparel & Luxury Goods – 5.0% | | | | | | | | | | | | | |
Canada Goose Holdings, Inc. (Canada)* | | | | | 5,789 | | | | | | 177,780 | | |
Lululemon Athletica, Inc.* | | | | | 547 | | | | | | 182,567 | | |
PVH Corp. | | | | | 2,025 | | | | | | 192,395 | | |
Steven Madden Ltd. | | | | | 4,668 | | | | | | 192,042 | | |
VF Corp. | | | | | 2,943 | | | | | | 191,913 | | |
Total Textiles, Apparel & Luxury Goods | | | | | | | | | | | 936,697 | | |
Total Common Stocks (Cost $21,525,679) | | | | | | | | | | | 18,550,912 | | |
MONEY MARKET FUND – 0.3% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b) (Cost $49,028) | | | | | 49,028 | | | | | | 49,028 | | |
Total Investments – 100.0% (Cost $21,574,707) | | | | | | | | | | | 18,599,940 | | |
Liabilities in Excess of Other Assets – (0.0)%(c) | | | | | | | | | | | (6,778) | | |
Net Assets – 100.0% | | | | | | | | | | $ | 18,593,162 | | |
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of January 31, 2022.
(c)
Less than 0.05%
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
ARK Transparency ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 18,550,912 | | | | | $ | — | | | | | $ | — | | | | | $ | 18,550,912 | | |
Money Market Fund | | | | | 49,028 | | | | | | — | | | | | | — | | | | | | 49,028 | | |
Total | | | | $ | 18,599,940 | | | | | $ | — | | | | | $ | — | | | | | $ | 18,599,940 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 96.4% | | | | | | | | | | | | | |
Aerospace & Defense – 2.3% | | | | | | | | | | | | | |
Aerojet Rocketdyne Holdings, Inc. | | | | | 85,665 | | | | | $ | 3,305,813 | | |
Hexcel Corp.* | | | | | 6,441 | | | | | | 336,027 | | |
Moog, Inc., Class A | | | | | 47,913 | | | | | | 3,652,887 | | |
Total Aerospace & Defense | | | | | | | | | | | 7,294,727 | | |
Air Freight & Logistics – 1.2% | | | | | | | | | | | | | |
United Parcel Service, Inc., Class B | | | | | 18,564 | | | | | | 3,753,826 | | |
Auto Components – 2.4% | | | | | | | | | | | | | |
Cie Generale des Etablissements Michelin SCA (France) | | | | | 21,793 | | | | | | 3,616,171 | | |
Exco Technologies Ltd. (Canada) | | | | | 481,477 | | | | | | 3,723,336 | | |
Total Auto Components | | | | | | | | | | | 7,339,507 | | |
Chemicals – 0.8% | | | | | | | | | | | | | |
5N Plus, Inc. (Canada)* | | | | | 183,698 | | | | | | 330,935 | | |
Arkema SA (France) | | | | | 2,351 | | | | | | 344,547 | | |
DuPont de Nemours, Inc. | | | | | 4,456 | | | | | | 341,330 | | |
Eastman Chemical Co. | | | | | 2,890 | | | | | | 343,708 | | |
Evonik Industries AG (Germany) | | | | | 10,663 | | | | | | 344,883 | | |
Koninklijke DSM NV (Netherlands) | | | | | 1,735 | | | | | | 323,660 | | |
Toray Industries, Inc. (Japan) | | | | | 55,325 | | | | | | 348,594 | | |
Total Chemicals | | | | | | | | | | | 2,377,657 | | |
Commercial Services & Supplies – 0.9% | | | | | | | | | | | | | |
PyroGenesis Canada, Inc. (Canada)* | | | | | 138,307 | | | | | | 378,640 | | |
Shapeways Holdings, Inc.* | | | | | 722,779 | | | | | | 2,312,893 | | |
Total Commercial Services & Supplies | | | | | | | | | | | 2,691,533 | | |
Electrical Equipment – 1.8% | | | | | | | | | | | | | |
AMETEK, Inc. | | | | | 38,417 | | | | | | 5,254,293 | | |
SGL Carbon SE (Germany)* | | | | | 45,502 | | | | | | 313,359 | | |
Total Electrical Equipment | | | | | | | | | | | 5,567,652 | | |
Electronic Equipment, Instruments & Components – 11.0% | |
FARO Technologies, Inc.* | | | | | 186,517 | | | | | | 10,129,738 | | |
Hexagon AB, Class B (Sweden) | | | | | 386,423 | | | | | | 5,146,919 | | |
Renishaw PLC (United Kingdom) | | | | | 140,225 | | | | | | 8,554,376 | | |
Trimble, Inc.* | | | | | 145,759 | | | | | | 10,517,970 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 34,349,003 | | |
Health Care Equipment & Supplies – 6.9% | | | | | | | | | | | | | |
Align Technology, Inc.* | | | | | 10,710 | | | | | | 5,301,021 | | |
Conformis, Inc.*† | | | | | 13,494,608 | | | | | | 8,036,039 | | |
Straumann Holding AG (Switzerland) | | | | | 5,044 | | | | | | 8,249,266 | | |
Total Health Care Equipment & Supplies | | | | | | | | | | | 21,586,326 | | |
Industrial Conglomerates – 2.4% | | | | | | | | | | | | | |
3M Co. | | | | | 2,035 | | | | | | 337,851 | | |
General Electric Co. | | | | | 38,237 | | | | | | 3,612,632 | | |
Siemens AG (Germany) | | | | | 22,599 | | | | | | 3,551,373 | | |
Total Industrial Conglomerates | | | | | | | | | | | 7,501,856 | | |
Internet & Direct Marketing Retail – 2.8% | |
Xometry, Inc., Class A* | | | | | 168,780 | | | | | | 8,709,048 | | |
Life Sciences Tools & Services – 2.3% | | | | | | | | | | | | | |
BICO Group AB (Sweden)* | | | | | 358,796 | | | | | | 7,110,700 | | |
Machinery – 20.7% | | | | | | | | | | | | | |
Desktop Metal, Inc., Class A* | | | | | 2,519,388 | | | | | | 10,304,297 | | |
Fathom Digital Manufacturing C* | | | | | 859,707 | | | | | | 7,659,989 | | |
Investments | | | Shares | | | Value | |
Lincoln Electric Holdings, Inc. | | | | | 29,024 | | | | | $ | 3,710,428 | | |
Markforged Holding Corp.* | | | | | 1,820,804 | | | | | | 8,612,403 | | |
Massivit 3d Printing Technologies Ltd. (Israel)* | | | | | 200,680 | | | | | | 1,169,693 | | |
OC Oerlikon Corp. AG (Switzerland) | | | | | 367,850 | | | | | | 3,536,981 | | |
Proto Labs, Inc.* | | | | | 175,305 | | | | | | 8,796,805 | | |
Sandvik AB (Sweden) | | | | | 13,032 | | | | | | 338,632 | | |
SLM Solutions Group AG (Germany)* | | | | | 621,284 | | | | | | 9,925,244 | | |
Velo3D Inc.* | | | | | 1,620,717 | | | | | | 10,453,625 | | |
Total Machinery | | | | | | | | | | | 64,508,097 | | |
Metals & Mining – 2.6% | | | | | | | | | | | | | |
Allegheny Technologies, Inc.* | | | | | 17,411 | | | | | | 318,447 | | |
Arconic Corp.* | | | | | 117,311 | | | | | | 3,628,429 | | |
Carpenter Technology Corp. | | | | | 11,767 | | | | | | 337,948 | | |
Kaiser Aluminum Corp. | | | | | 37,473 | | | | | | 3,588,040 | | |
voestalpine AG (Austria) | | | | | 9,316 | | | | | | 307,910 | | �� |
Total Metals & Mining | | | | | | | | | | | 8,180,774 | | |
Shell Companies – 2.8% | | | | | | | | | | | | | |
Atlantic Coastal Acquisition Corp., Class A* | | | | | 895,660 | | | | | | 8,840,164 | | |
Software – 23.6% | | | | | | | | | | | | | |
Altair Engineering, Inc., Class A* | | | | | 176,624 | | | | | | 11,113,182 | | |
ANSYS, Inc.* | | | | | 31,766 | | | | | | 10,800,758 | | |
Autodesk, Inc.* | | | | | 43,177 | | | | | | 10,785,183 | | |
Dassault Systemes SE (France) | | | | | 202,463 | | | | | | 9,655,501 | | |
Materialise NV (Belgium)*(a) | | | | | 464,388 | | | | | | 9,524,598 | | |
Microsoft Corp. | | | | | 35,094 | | | | | | 10,913,532 | | |
PTC, Inc.* | | | | | 91,443 | | | | | | 10,631,163 | | |
Total Software | | | | | | | | | | | 73,423,917 | | |
Technology Hardware, Storage & Peripherals – 11.9% | | | | | | | | | | | | | |
3D Systems Corp.* | | | | | 480,207 | | | | | | 8,595,705 | | |
Eastman Kodak Co.* | | | | | 84,415 | | | | | | 331,751 | | |
HP, Inc. | | | | | 243,345 | | | | | | 8,938,062 | | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 2,606,277 | | | | | | 9,565,036 | | |
Stratasys Ltd.* | | | | | 390,790 | | | | | | 9,316,434 | | |
Xerox Holdings Corp. | | | | | 15,725 | | | | | | 331,955 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 37,078,943 | | |
Total Common Stocks (Cost $383,621,074) | | | | | | | | | | | 300,313,730 | | |
PREFERRED STOCK – 0.1% | | | | | | | | | | | | | |
Household Products – 0.1% | | | | | | | | | | | | | |
Henkel AG & Co. KGaA (Germany) (Cost $431,677) | | | | | 4,013 | | | | | | 326,677 | | |
MONEY MARKET FUND – 3.6% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b) (Cost $11,092,963) | | | | | 11,092,963 | | | | | | 11,092,963 | | |
Total Investments – 100.1% (Cost $395,145,714) | | | | | | | | | | | 311,733,370 | | |
Liabilities in Excess of Other Assets – (0.1)% | | | | | | | | | | | (429,804) | | |
Net Assets – 100.0% | | | | | | | | | | $ | 311,303,566 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
The 3D Printing ETF
January 31, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 1/31/2022 | | | Value ($) at 1/31/2022 | |
Common Stocks – 2.6% | |
Health Care Equipment & Supplies – 2.6% | | | | | | | | | |
Conformis, Inc. | |
19,209,575 | | | | | 5,406,416 | | | | | | (3,701,934) | | | | | | (532,871) | | | | | | (12,345,147) | | | | | | — | | | | | | — | | | | | | 13,494,608 | | | | | | 8,036,039 | | |
Machinery – 0.0% | |
ExOne (The) Co. | |
18,815,801 | | | | | — | | | | | | (35,228,058) | | | | | | (6,866,123) | | | | | | 23,278,380 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$38,025,376 | | | | $ | 5,406,416 | | | | | $ | (38,929,992) | | | | | $ | (7,398,994) | | | | | $ | 10,933,233 | | | | | $ | — | | | | | $ | — | | | | | | 13,494,608 | | | | | $ | 8,036,039 | | |
*
Non-income producing security
†
Affiliated security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of January 31, 2022.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
The 3D Printing ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 300,313,730 | | | | | $ | — | | | | | $ | — | | | | | $ | 300,313,730 | | |
Preferred Stock‡ | | | | | 326,677 | | | | | | — | | | | | | — | | | | | | 326,677 | | |
Money Market Fund | | | | | 11,092,963 | | | | | | — | | | | | | — | | | | | | 11,092,963 | | |
Total | | | | $ | 311,733,370 | | | | | $ | — | | | | | $ | — | | | | | $ | 311,733,370 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
The ARK Israel Innovative Technology ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
COMMON STOCKS – 101.5% | | | | | | | | | | | | | |
Aerospace & Defense – 3.1% | | | | | | | | | | | | | |
Elbit Systems Ltd. (Israel) | | | | | 15,508 | | | | | $ | 2,576,501 | | |
RADA Electronic Industries Ltd. (Israel)* | | | | | 272,178 | | | | | | 2,612,909 | | |
Total Aerospace & Defense | | | | | | | | | | | 5,189,410 | | |
Auto Components – 1.5% | | | | | | | | | | | | | |
REE Automotive Ltd., Class A (Israel)* | | | | | 597,465 | | | | | | 2,479,480 | | |
Biotechnology – 8.5% | | | | | | | | | | | | | |
BioLine RX Ltd. (Israel)*(a) | | | | | 676 | | | | | | 1,230 | | |
Chemomab Therapeutics Ltd. (Israel)*(a) | | | | | 97,537 | | | | | | 477,931 | | |
Collplant Biotechnologies Ltd. (Israel)* | | | | | 235,667 | | | | | | 2,314,250 | | |
Enlivex Therapeutics Ltd. (Israel)* | | | | | 473,300 | | | | | | 2,527,422 | | |
Entera Bio Ltd. (Israel)* | | | | | 233,361 | | | | | | 534,397 | | |
Gamida Cell Ltd. (Israel)* | | | | | 878,183 | | | | | | 2,924,350 | | |
Kamada Ltd. (Israel)* | | | | | 434,214 | | | | | | 2,614,557 | | |
UroGen Pharma Ltd.* | | | | | 343,703 | | | | | | 2,653,387 | | |
Vascular Biogenics Ltd. (Israel)* | | | | | 277,216 | | | | | | 363,153 | | |
Total Biotechnology | | | | | | | | | | | 14,410,677 | | |
Communications Equipment – 9.4% | | | | | | | | | | | | | |
AudioCodes Ltd. (Israel) | | | | | 89,224 | | | | | | 2,642,815 | | |
Ceragon Networks Ltd. (Israel)* | | | | | 1,147,593 | | | | | | 2,639,464 | | |
Gilat Satellite Networks Ltd. (Israel)* | | | | | 353,788 | | | | | | 2,678,175 | | |
Ituran Location and Control Ltd. (Israel) | | | | | 107,865 | | | | | | 2,595,232 | | |
Radware Ltd. (Israel)* | | | | | 80,603 | | | | | | 2,710,679 | | |
Silicom Ltd. (Israel)* | | | | | 59,957 | | | | | | 2,693,868 | | |
Total Communications Equipment | | | | | | | | | | | 15,960,233 | | |
Diversified Telecommunication – 1.5% | | | | | | | | | | | | | |
Bezeq The Israeli Telecommunication Corp. Ltd. (Israel)* | | | | | 1,533,670 | | | | | | 2,624,594 | | |
Electrical Equipment – 2.5% | | | | | | | | | | | | | |
Augwind Energy Tech Storage Ltd. (Israel)* | | | | | 218,124 | | | | | | 2,149,266 | | |
Gencell Ltd. (Israel)* | | | | | 816,858 | | | | | | 2,067,822 | | |
Total Electrical Equipment | | | | | | | | | | | 4,217,088 | | |
Electronic Equipment, Instruments & Components – 5.7% | |
Arbe Robotics Ltd. (Israel)* | | | | | 250,805 | | | | | | 2,076,665 | | |
Innoviz Technologies Ltd. (Israel)* | | | | | 707,582 | | | | | | 2,858,631 | | |
Nayax Ltd. (Israel)* | | | | | 845,874 | | | | | | 2,171,738 | | |
Priortech Ltd. (Israel)* | | | | | 79,511 | | | | | | 2,531,973 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 9,639,007 | | |
Entertainment – 1.4% | | | | | | | | | | | | | |
Playtika Holding Corp.* | | | | | 142,497 | | | | | | 2,426,724 | | |
Health Care Equipment & Supplies – 3.3% | | | | | | | | | | | | | |
Check Cap Ltd.* | | | | | 1,178 | | | | | | 671 | | |
Inmode Ltd.* | | | | | 60,854 | | | | | | 2,934,989 | | |
Nano-X Imaging Ltd. (Israel)* | | | | | 235,857 | | | | | | 2,676,977 | | |
Total Health Care Equipment & Supplies | | | | | | | | | | | 5,612,637 | | |
Hotels, Restaurants & Leisure – 1.7% | | | | | | | | | | | | | |
Fattal Holdings 1998 Ltd. (Israel)* | | | | | 24,153 | | | | | | 2,881,970 | | |
Household Durables – 1.6% | | | | | | | | | | | | | |
Electra Consumer Products 1970 Ltd. (Israel) | | | | | 42,458 | | | | | | 2,657,146 | | |
Investments | | | Shares | | | Value | |
Interactive Media & Services – 1.6% | | | | | | | | | | | | | |
Taboola.com Ltd. (Israel)* | | | | | 436,097 | | | | | $ | 2,638,387 | | |
Internet & Direct Marketing Retail – 1.7% | | | | | | | | | | | | | |
Fiverr International Ltd.* | | | | | 33,112 | | | | | | 2,824,785 | | |
IT Services – 6.3% | | | | | | | | | | | | | |
Malam – Team Ltd. (Israel) | | | | | 78,820 | | | | | | 2,641,942 | | |
Matrix IT Ltd. (Israel) | | | | | 98,064 | | | | | | 2,731,504 | | |
One Software Technologies Ltd. (Israel) | | | | | 151,832 | | | | | | 2,647,730 | | |
Wix.com Ltd. (Israel)* | | | | | 20,428 | | | | | | 2,683,626 | | |
Total IT Services | | | | | | | | | | | 10,704,802 | | |
Life Sciences Tools & Services – 1.5% | | | | | | | | | | | | | |
Compugen Ltd. (Israel)* | | | | | 719,698 | | | | | | 2,554,928 | | |
Machinery – 3.2% | | | | | | | | | | | | | |
Kornit Digital Ltd. (Israel)* | | | | | 26,530 | | | | | | 2,787,242 | | |
Plasson Industries Ltd. (Israel) | | | | | 35,486 | | | | | | 2,654,667 | | |
Total Machinery | | | | | | | | | | | 5,441,909 | | |
Media – 1.7% | | | | | | | | | | | | | |
Perion Network Ltd. (Israel)* | | | | | 140,984 | | | | | | 2,890,172 | | |
Pharmaceuticals – 5.2% | | | | | | | | | | | | | |
Intercure Ltd. (Israel)* | | | | | 257 | | | | | | 1,576 | | |
MediWound Ltd. (Israel)* | | | | | 236,756 | | | | | | 589,522 | | |
PolyPid Ltd. (Israel)* | | | | | 142,382 | | | | | | 635,024 | | |
Purple Biotech Ltd. (Israel)*(a) | | | | | 103,464 | | | | | | 264,868 | | |
Redhill Biopharma Ltd. (Israel)*(a) | | | | | 738,314 | | | | | | 1,941,766 | | |
Taro Pharmaceutical Industries Ltd.* | | | | | 57,268 | | | | | | 2,681,288 | | |
Teva Pharmaceutical Industries Ltd. (Israel)*(a) | | | | | 309,210 | | | | | | 2,606,640 | | |
Total Pharmaceuticals | | | | | | | | | | | 8,720,684 | | |
Professional Services – 1.6% | | | | | | | | | | | | | |
Danel Adir Yeoshua Ltd. (Israel) | | | | | 11,568 | | | | | | 2,748,560 | | |
Semiconductors & Semiconductor Equipment – 6.3% | |
Camtek Ltd. (Israel)* | | | | | 70,375 | | | | | | 2,615,839 | | |
Nova Ltd. (Israel)* | | | | | 22,224 | | | | | | 2,629,099 | | |
SolarEdge Technologies, Inc.* | | | | | 11,764 | | | | | | 2,802,420 | | |
Tower Semiconductor Ltd. (Israel)* | | | | | 73,863 | | | | | | 2,537,194 | | |
Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 10,584,552 | | |
Software – 25.4% | | | | | | | | | | | | | |
Allot Ltd. (Israel)* | | | | | 270,861 | | | | | | 2,600,266 | | |
Cellebrite DI Ltd. (Japan)* | | | | | 422,146 | | | | | | 2,532,876 | | |
Check Point Software Technologies Ltd. (Israel)* | | | | | 22,099 | | | | | | 2,674,200 | | |
Cognyte Software Ltd. (Israel)* | | | | | 220,811 | | | | | | 2,395,799 | | |
CyberArk Software Ltd.* | | | | | 19,386 | | | | | | 2,658,790 | | |
Hilan Ltd. (Israel) | | | | | 44,277 | | | | | | 2,835,328 | | |
ironSource Ltd., Class A (Israel)* | | | | | 399,940 | | | | | | 2,763,586 | | |
JFrog Ltd. (Israel)* | | | | | 109,011 | | | | | | 2,912,774 | | |
Magic Software Enterprises Ltd. (Israel) | | | | | 143,054 | | | | | | 2,722,428 | | |
Monday.com Ltd.* | | | | | 12,995 | | | | | | 2,720,113 | | |
Nice Ltd. (Israel)*(a) | | | | | 10,766 | | | | | | 2,756,742 | | |
Riskified Ltd., Class A* | | | | | 396,089 | | | | | | 2,760,740 | | |
Sapiens International Corp. NV (Israel) | | | | | 88,198 | | | | | | 2,808,224 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (concluded)
The ARK Israel Innovative Technology ETF
January 31, 2022 (Unaudited)
Investments | | | Shares | | | Value | |
SimilarWeb Ltd. (Israel)* | | | | | 164,430 | | | | | $ | 2,366,148 | | |
Tufin Software Technologies Ltd. (Israel)* | | | | | 300,784 | | | | | | 2,661,938 | | |
WalkMe Ltd. (Israel)* | | | | | 164,308 | | | | | | 2,863,889 | | |
Total Software | | | | | | | | | | | 43,033,841 | | |
Technology Hardware, Storage & Peripherals – 3.4% | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 814,013 | | | | | | 2,987,428 | | |
Stratasys Ltd.* | | | | | 117,567 | | | | | | 2,802,797 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 5,790,225 | | |
Wireless Telecommunication Services – 3.4% | |
Cellcom Israel Ltd. (Israel)* | | | | | 477,506 | | | | | | 2,786,231 | | |
Partner Communications Co. Ltd. (Israel)* | | | | | 332,222 | | | | | | 2,937,668 | | |
Total Wireless Telecommunication Services | | | | | | | | | | | 5,723,899 | | |
Total Common Stocks (Cost $215,407,450) | | | | | | | | | | | 171,755,710 | | |
Total Investments – 101.5% (Cost $215,407,450) | | | | | | | | | | | 171,755,710 | | |
Liabilities in Excess of Other Assets – (1.5)% | | | | | | | | | | | (2,536,306) | | |
Net Assets – 100.0% | | | | | | | | | | $ | 169,219,404 | | |
*
Non-income producing security
(a)
American Depositary Receipt
Country | | | Value | | | % of Net Assets | |
Israel | | | | $ | 141,956,130 | | | | | | 83.9% | | |
Japan | | | | | 2,532,876 | | | | | | 1.5 | | |
United States | | | | | 27,266,704 | | | | | | 16.1 | | |
Total Investments | | | | | 171,755,710 | | | | | | 101.5 | | |
Liabilities in Excess of Other Assets | | | | | (2,536,306) | | | | | | (1.5) | | |
Net Assets | | | | $ | 169,219,404 | | | | | | 100.0% | | |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2022, based upon the three levels defined above:
The ARK Israel Innovative Technology ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 171,755,710 | | | | | $ | — | | | | | $ | — | | | | | $ | 171,755,710 | | |
Total | | | | $ | 171,755,710 | | | | | $ | — | | | | | $ | — | | | | | $ | 171,755,710 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
Statements of Assets and Liabilities
January 31, 2022 (Unaudited)
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | |
ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities at market value (Note 2) | | | | $ | 3,199,152,508 | | | | | $ | 1,411,120,455 | | | | | $ | 9,269,743,277 | | | | | $ | 2,600,326,612 | | |
Investments in affiliated securities at market value (Note 2) | | | | | 882,564,306 | | | | | | 227,207,046 | | | | | | 3,702,097,402 | | | | | | 84,425,175 | | |
Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends and interest | | | | | 379,779 | | | | | | 367,530 | | | | | | 342 | | | | | | 95 | | |
Capital shares sold | | | | | 17,401,905 | | | | | | — | | | | | | 297,558,536 | | | | | | — | | |
Investment securities sold | | | | | 61,798,651 | | | | | | 13,874,555 | | | | | | 133,372,173 | | | | | | 76,344,067 | | |
Reclaims | | | | | 5,173,433 | | | | | | 9,177 | | | | | | 1,778,642 | | | | | | — | | |
Total Assets | | | | | 4,166,470,582 | | | | | | 1,652,578,763 | | | | | | 13,404,550,372 | | | | | | 2,761,095,949 | | |
LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Due to custodian | | | | | 84,145 | | | | | | 25,033 | | | | | | 392,943 | | | | | | 728 | | |
Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Capital shares purchased | | | | | 35,216,027 | | | | | | 6,405,666 | | | | | | 55,475,334 | | | | | | 39,688,378 | | |
Investment securities purchased | | | | | 36,253,506 | | | | | | 4,627,879 | | | | | | 371,739,238 | | | | | | 26,727,257 | | |
Management fees (Note 3) | | | | | 2,734,563 | | | | | | 1,200,952 | | | | | | 8,663,515 | | | | | | 1,987,742 | | |
Total Liabilities | | | | | 74,288,241 | | | | | | 12,259,530 | | | | | | 436,271,030 | | | | | | 68,404,105 | | |
NET ASSETS | | | | $ | 4,092,182,341 | | | | | $ | 1,640,319,233 | | | | | $ | 12,968,279,342 | | | | | $ | 2,692,691,844 | | |
NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
Paid-in capital | | | | $ | 7,893,648,545 | | | | | $ | 2,086,196,576 | | | | | $ | 19,854,499,336 | | | | | $ | 4,156,727,174 | | |
Total accumulated loss | | | | | (3,801,466,204) | | | | | | (445,877,343) | | | | | | (6,886,219,994) | | | | | | (1,464,035,330) | | |
NET ASSETS | | | | $ | 4,092,182,341 | | | | | $ | 1,640,319,233 | | | | | $ | 12,968,279,342 | | | | | $ | 2,692,691,844 | | |
Shares outstanding | | | | | 82,305,000 | | | | | | 24,850,000 | | | | | | 172,150,000 | | | | | | 28,400,000 | | |
Net asset value, per share | | | | $ | 49.72 | | | | | $ | 66.01 | | | | | $ | 75.33 | | | | | $ | 94.81 | | |
Investments in non-affiliated securities at cost | | | | $ | 5,682,513,703 | | | | | $ | 1,774,294,972 | | | | | $ | 14,185,722,040 | | | | | $ | 4,117,953,745 | | |
Investments in affiliated securities at cost | | | | $ | 2,036,035,063 | | | | | $ | 432,329,101 | | | | | $ | 6,489,691,145 | | | | | $ | 154,739,514 | | |
See accompanying Notes to Financial Statements.
Statements of Assets and Liabilities (continued)
January 31, 2022 (Unaudited)
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | | | ARK Transparency ETF | | | The 3D Printing ETF | |
ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities at market value (Note 2) | | | | $ | 1,585,277,166 | | | | | $ | 348,145,215 | | | | | $ | 18,599,940 | | | | | $ | 303,697,331 | | |
Investments in affiliated securities at market value (Note 2) | | | | | — | | | | | | 29,797,772 | | | | | | — | | | | | | 8,036,039 | | |
Cash | | | | | 100,963 | | | | | | 34 | | | | | | — | | | | | | — | | |
Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends and interest | | | | | 651,575 | | | | | | 31,020 | | | | | | 2,062 | | | | | | 33,379 | | |
Investment securities sold | | | | | 53,424,083 | | | | | | 4,619,990 | | | | | | — | | | | | | 5,319,632 | | |
Reclaims | | | | | — | | | | | | 76,142 | | | | | | — | | | | | | 120,428 | | |
Prepaid expenses | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Total Assets | | | | | 1,639,453,787 | | | | | | 382,670,173 | | | | | | 18,602,002 | | | | | | 317,206,809 | | |
LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Due to custodian | | | | | — | | | | | | — | | | | | | 45 | | | | | | 104,306 | | |
Due to custodian for foreign currency | | | | | 3,396 | | | | | | 3,476 | | | | | | — | | | | | | 8,931 | | |
Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Capital shares purchased | | | | | — | | | | | | 1,583,281 | | | | | | — | | | | | | 4,349,290 | | |
Investment securities purchased | | | | | 36,253,258 | | | | | | 1,583,683 | | | | | | — | | | | | | 1,244,714 | | |
Management fees (Note 3) | | | | | 1,137,973 | | | | | | 245,367 | | | | | | 8,795 | | | | | | 193,027 | | |
Other accrued expenses | | | | | — | | | | | | — | | | | | | — | | | | | | 2,975 | | |
Total Liabilities | | | | | 37,394,627 | | | | | | 3,415,807 | | | | | | 8,840 | | | | | | 5,903,243 | | |
NET ASSETS | | | | $ | 1,602,059,160 | | | | | $ | 379,254,366 | | | | | $ | 18,593,162 | | | | | $ | 311,303,566 | | |
NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
Paid-in capital | | | | $ | 2,861,850,326 | | | | | $ | 490,404,879 | | | | | $ | 21,582,673 | | | | | $ | 485,769,207 | | |
Total accumulated loss | | | | | (1,259,791,166) | | | | | | (111,150,513) | | | | | | (2,989,511) | | | | | | (174,465,641) | | |
NET ASSETS | | | | $ | 1,602,059,160 | | | | | $ | 379,254,366 | | | | | $ | 18,593,162 | | | | | $ | 311,303,566 | | |
Shares outstanding | | | | | 49,400,001 | | | | | | 23,150,001 | | | | | | 1,100,001 | | | | | | 10,300,001 | | |
Net asset value, per share | | | | $ | 32.43 | | | | | $ | 16.38 | | | | | $ | 16.90 | | | | | $ | 30.22 | | |
Investments in non-affiliated securities at cost | | | | $ | 2,410,811,073 | | | | | $ | 436,793,861 | | | | | $ | 21,574,707 | | | | | $ | 379,554,665 | | |
Investments in affiliated securities at cost | | | | $ | — | | | | | $ | 38,824,372 | | | | | $ | — | | | | | $ | 15,591,049 | | |
See accompanying Notes to Financial Statements.
Statements of Assets and Liabilities (concluded)
January 31, 2022 (Unaudited)
| | | The ARK Israel Innovative Technology ETF | |
ASSETS: | | | | | | | |
Investments in non-affiliated securities at market value (Note 2) | | | | $ | 171,755,710 | | |
Receivables: | | | | | | | |
Dividends and interest | | | | | 12 | | |
Capital shares sold | | | | | 1,253,487 | | |
Investment securities sold | | | | | 1,001,205 | | |
Total Assets | | | | | 174,010,414 | | |
LIABILITIES: | | | | | | | |
Due to custodian | | | | | 3,457,599 | | |
Due to custodian for foreign currency | | | | | 3,130 | | |
Payables: | | | | | | | |
Investment securities purchased | | | | | 1,250,175 | | |
Management fees (Note 3) | | | | | 78,463 | | |
Other accrued expenses | | | | | 1,643 | | |
Total Liabilities | | | | | 4,791,010 | | |
NET ASSETS | | | | $ | 169,219,404 | | |
NET ASSETS CONSIST OF: | | | | | | | |
Paid-in capital | | | | $ | 253,437,241 | | |
Total accumulated loss | | | | | (84,217,837) | | |
NET ASSETS | | | | $ | 169,219,404 | | |
Shares outstanding | | | | | 6,750,001 | | |
Net asset value, per share | | | | $ | 25.07 | | |
Investments in non-affiliated securities at cost | | | | $ | 215,407,450 | | |
See accompanying Notes to Financial Statements.
Statements of Operations
For the Period Ended January 31, 2022 (Unaudited)
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | |
INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
Unaffiliated dividend income | | | | $ | 6,542,345 | | | | | $ | 4,320,552 | | | | | $ | 640,025 | | | | | $ | 1,677 | | |
Foreign withholding tax | | | | | (603,721) | | | | | | (363,290) | | | | | | (79,832) | | | | | | — | | |
Total Income | | | | | 5,938,624 | | | | | | 3,957,262 | | | | | | 560,193 | | | | | | 1,677 | | |
EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Management fees (Note 3) | | | | | 25,139,959 | | | | | | 9,305,250 | | | | | | 72,452,561 | | | | | | 18,367,657 | | |
Overdraft expense | | | | | 71 | | | | | | 29 | | | | | | — | | | | | | 3 | | |
Total Expenses | | | | | 25,140,030 | | | | | | 9,305,279 | | | | | | 72,452,561 | | | | | | 18,367,660 | | |
Net Investment Loss(1) | | | | | (19,201,406) | | | | | | (5,348,017) | | | | | | (71,892,368) | | | | | | (18,365,983) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (243,198,057) | | | | | | 66,647,038 | | | | | | (375,109,909) | | | | | | (77,166,667) | | |
Investments in affiliated securities | | | | | (65,041,148) | | | | | | — | | | | | | (364,293,941) | | | | | | (1,630,780) | | |
In-kind redemptions – non-affiliated securities | | | | | 120,091,965 | | | | | | 107,186,670 | | | | | | 1,272,446,220 | | | | | | 349,366,370 | | |
In-kind redemptions – affiliated securities | | | | | 120,189,699 | | | | | | (5,084,904) | | | | | | 569,263,532 | | | | | | (2,683,660) | | |
Net realized gain (loss) | | | | | (67,957,541) | | | | | | 168,748,804 | | | | | | 1,102,305,902 | | | | | | 267,885,263 | | |
Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (1,897,874,149) | | | | | | (387,722,833) | | | | | | (5,702,213,377) | | | | | | (1,799,008,078) | | |
Investments in affiliated securities | | | | | (1,138,909,155) | | | | | | (173,980,697) | | | | | | (2,819,070,950) | | | | | | (57,579,314) | | |
Change in unrealized depreciation | | | | | (3,036,783,304) | | | | | | (561,703,530) | | | | | | (8,521,284,327) | | | | | | (1,856,587,392) | | |
Net realized and unrealized loss on investments and foreign currency translation | | | | | (3,104,740,845) | | | | | | (392,954,726) | | | | | | (7,418,978,425) | | | | | | (1,588,702,129) | | |
Net Decrease in Net Assets Resulting From Operations | | | | $ | (3,123,942,251) | | | | | $ | (398,302,743) | | | | | $ | (7,490,870,793) | | | | | $ | (1,607,068,112) | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Operations (continued)
For the Period Ended January 31, 2022 (Unaudited)
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | | | ARK Transparency ETF(1) | | | The 3D Printing ETF | |
INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
Unaffiliated dividend income | | | | $ | 1,473,140 | | | | | $ | 1,272,955 | | | | | $ | 40,921 | | | | | $ | 926,294 | | |
Affiliated dividend income | | | | | — | | | | | | 604 | | | | | | — | | | | | | — | | |
Foreign withholding tax | | | | | (13,222) | | | | | | (57,787) | | | | | | — | | | | | | (16,339) | | |
Total Income | | | | | 1,459,918 | | | | | | 1,215,772 | | | | | | 40,921 | | | | | | 909,955 | | |
EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Management fees (Note 3) | | | | | 11,352,309 | | | | | | 1,997,405 | | | | | | 14,478 | | | | | | 1,480,272 | | |
Overdraft expense | | | | | 51 | | | | | | 92 | | | | | | — | | | | | | 3,685 | | |
Other expenses | | | | | — | | | | | | — | | | | | | — | | | | | | 22,710 | | |
Total Expenses | | | | | 11,352,360 | | | | | | 1,997,497 | | | | | | 14,478 | | | | | | 1,506,667 | | |
Less expense waivers and reimbursements | | | | | — | | | | | | (136,454)(3) | | | | | | — | | | | | | — | | |
Net Expenses | | | | | 11,352,360 | | | | | | 1,861,043 | | | | | | 14,478 | | | | | | 1,506,667 | | |
Net Investment Income (Loss)(2) | | | | | (9,892,442) | | | | | | (645,271) | | | | | | 26,443 | | | | | | (596,712) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (301,437,099) | | | | | | (1,831,971) | | | | | | (9,827) | | | | | | (66,580,676) | | |
Investments in affiliated securities | | | | | — | | | | | | — | | | | | | — | | | | | | (8,006,682) | | |
Foreign currency transactions | | | | | (369,300) | | | | | | (5,199) | | | | | | — | | | | | | (100,588) | | |
In-kind redemptions – non-affiliated securities | | | | | 131,536,219 | | | | | | 6,411,256 | | | | | | — | | | | | | 3,716,073 | | |
In-kind redemptions – affiliated securities | | | | | — | | | | | | (566,410) | | | | | | — | | | | | | 607,688 | | |
Net realized gain (loss) | | | | | (170,270,180) | | | | | | 4,007,676 | | | | | | (9,827) | | | | | | (70,364,185) | | |
Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (851,235,389) | | | | | | (94,422,441) | | | | | | (2,974,767) | | | | | | (32,870,049) | | |
Investments in affiliated securities | | | | | — | | | | | | (7,829,915) | | | | | | — | | | | | | 10,933,233 | | |
Foreign currency translation | | | | | 14,332 | | | | | | (3,578) | | | | | | — | | | | | | (3,453) | | |
Change in unrealized depreciation | | | | | (851,221,057) | | | | | | (102,255,934) | | | | | | (2,974,767) | | | | | | (21,940,269) | | |
Net realized and unrealized loss on investments and foreign currency translation | | | | | (1,021,491,237) | | | | | | (98,248,258) | | | | | | (2,984,594) | | | | | | (92,304,454) | | |
Net Decrease in Net Assets Resulting From Operations | | | | $ | (1,031,383,679) | | | | | $ | (98,893,529) | | | | | $ | (2,958,151) | | | | | $ | (92,901,166) | | |
(1)
Represents the period December 8, 2021 (commencement of operations) to January 31, 2022.
(2)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(3)
See Notes to Financial Statements (Note 3).
See accompanying Notes to Financial Statements.
Statements of Operations (concluded)
For the Period Ended January 31, 2022 (Unaudited)
| | | The ARK Israel Innovative Technology ETF | |
INVESTMENT INCOME: | | | | | | | |
Unaffiliated dividend income | | | | $ | 542,425 | | |
Foreign withholding tax | | | | | (128,428) | | |
Total Income | | | | | 413,997 | | |
EXPENSES: | | | | | | | |
Management fees (Note 3) | | | | | 601,115 | | |
Overdraft expense | | | | | 1,710 | | |
Other expenses | | | | | 12,525 | | |
Total Expenses | | | | | 615,350 | | |
Net Investment Loss(1) | | | | | (201,353) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | |
Net realized gain (loss) on: | | | | | | | |
Investments in non-affiliated securities | | | | | (23,854,962) | | |
Foreign currency transactions | | | | | (172,369) | | |
In-kind redemptions – non-affiliated securities | | | | | 5,369,828 | | |
Net realized loss | | | | | (18,657,503) | | |
Change in unrealized appreciation (depreciation) on: | | | | | | | |
Investments in non-affiliated securities | | | | | (20,045,950) | | |
Foreign currency translation | | | | | 508 | | |
Change in unrealized depreciation | | | | | (20,045,442) | | |
Net realized and unrealized loss on investments and foreign currency translation | | | | | (38,702,945) | | |
Net Decrease in Net Assets Resulting From Operations | | | | $ | (38,904,298) | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | |
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | |
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss(1) | | | | $ | (19,201,406) | | | | | $ | (19,302,419) | | | | | $ | (5,348,017) | | | | | $ | (8,696,574) | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (67,957,541) | | | | | | 1,031,287,805 | | | | | | 168,748,804 | | | | | | 327,433,269 | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (3,036,783,304) | | | | | | (1,002,959,757) | | | | | | (561,703,530) | | | | | | (98,689,408) | | |
Net increase (decrease) in net assets resulting from operations | | | | | (3,123,942,251) | | | | | | 9,025,629 | | | | | | (398,302,743) | | | | | | 220,047,287 | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (32,103,552) | | | | | | (62,384,714) | | | | | | (17,227,749) | | | | | | (14,434,200) | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 1,413,617,216 | | | | | | 10,605,437,472 | | | | | | 27,404,750 | | | | | | 3,123,783,591 | | |
Cost of shares redeemed | | | | | (2,753,402,821) | | | | | | (3,553,920,853) | | | | | | (778,194,762) | | | | | | (970,644,388) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (1,339,785,605) | | | | | | 7,051,516,619 | | | | | | (750,790,012) | | | | | | 2,153,139,203 | | |
Increase (decrease) in net assets | | | | | (4,495,831,408) | | | | | | 6,998,157,534 | | | | | | (1,166,320,504) | | | | | | 2,358,752,290 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of period | | | | | 8,588,013,749 | | | | | | 1,589,856,215 | | | | | | 2,806,639,737 | | | | | | 447,887,447 | | |
End of period | | | | $ | 4,092,182,341 | | | | | $ | 8,588,013,749 | | | | | $ | 1,640,319,233 | | | | | $ | 2,806,639,737 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | 101,755,000 | | | | | | 29,605,000 | | | | | | 34,600,000 | | | | | | 8,500,000 | | |
Shares sold | | | | | 22,550,000 | | | | | | 113,400,000 | | | | | | 400,000 | | | | | | 38,100,000 | | |
Shares redeemed | | | | | (42,000,000) | | | | | | (41,250,000) | | | | | | (10,150,000) | | | | | | (12,000,000) | | |
Shares outstanding, end of period | | | | | 82,305,000 | | | | | | 101,755,000 | | | | | | 24,850,000 | | | | | | 34,600,000 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (continued)
| | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | ��� |
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | |
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss(1) | | | | $ | (71,892,368) | | | | | $ | (112,129,063) | | | | | $ | (18,365,983) | | | | | $ | (35,094,816) | | |
Net realized gain on investments and foreign currency transactions | | | | | 1,102,305,902 | | | | | | 4,139,590,008 | | | | | | 267,885,263 | | | | | | 1,184,280,101 | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (8,521,284,327) | | | | | | (1,127,085,783) | | | | | | (1,856,587,392) | | | | | | (245,805,204) | | |
Net increase (decrease) in net assets resulting from operations | | | | | (7,490,870,793) | | | | | | 2,900,375,162 | | | | | | (1,607,068,112) | | | | | | 903,380,081 | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (133,975,984) | | | | | | (291,314,175) | | | | | | (106,224,276) | | | | | | (68,580,176) | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 8,183,224,271 | | | | | | 24,078,752,000 | | | | | | 557,610,022 | | | | | | 6,018,769,322 | | |
Cost of shares redeemed | | | | | (10,085,527,006) | | | | | | (10,324,983,217) | | | | | | (1,965,265,706) | | | | | | (2,959,974,254) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (1,902,302,735) | | | | | | 13,753,768,783 | | | | | | (1,407,655,684) | | | | | | 3,058,795,068 | | |
Increase (decrease) in net assets | | | | | (9,527,149,512) | | | | | | 16,362,829,770 | | | | | | (3,120,948,072) | | | | | | 3,893,594,973 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of period | | | | | 22,495,428,854 | | | | | | 6,132,599,084 | | | | | | 5,813,639,916 | | | | | | 1,920,044,943 | | |
End of period | | | | $ | 12,968,279,342 | | | | | $ | 22,495,428,854 | | | | | $ | 2,692,691,844 | | | | | $ | 5,813,639,916 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | 187,600,000 | | | | | | 76,300,000 | | | | | | 39,450,000 | | | | | | 19,300,000 | | |
Shares sold | | | | | 83,100,000 | | | | | | 198,750,000 | | | | | | 4,400,000 | | | | | | 41,000,000 | | |
Shares redeemed | | | | | (98,550,000) | | | | | | (87,450,000) | | | | | | (15,450,000) | | | | | | (20,850,000) | | |
Shares outstanding, end of period | | | | | 172,150,000 | | | | | | 187,600,000 | | | | | | 28,400,000 | | | | | | 39,450,000 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (continued)
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | |
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Six Months Ended January 31, 2022 (Unaudited) | | | March 30, 2021(1) to July 31, 2021 | |
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss(2) | | | | $ | (9,892,442) | | | | | $ | (15,112,557) | | | | | $ | (645,271) | | | | | $ | (527,856) | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (170,270,180) | | | | | | 50,001,871 | | | | | | 4,007,676 | | | | | | (15,013,887) | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (851,221,057) | | | | | | (57,496,048) | | | | | | (102,255,934) | | | | | | 4,575,517 | | |
Net decrease in net assets resulting from operations | | | | | (1,031,383,679) | | | | | | (22,606,734) | | | | | | (98,893,529) | | | | | | (10,966,226) | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | — | | | | | | (7,191,728) | | | | | | — | | | | | | — | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 34,884,995 | | | | | | 4,293,672,073 | | | | | | — | | | | | | 692,463,575 | | |
Cost of shares redeemed | | | | | (1,011,711,216) | | | | | | (1,000,941,520) | | | | | | (129,405,409) | | | | | | (73,944,045) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (976,826,221) | | | | | | 3,292,730,553 | | | | | | (129,405,409) | | | | | | 618,519,530 | | |
Increase (decrease) in net assets | | | | | (2,008,209,900) | | | | | | 3,262,932,091 | | | | | | (228,298,938) | | | | | | 607,553,304 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of period | | | | | 3,610,269,060 | | | | | | 347,336,969 | | | | | | 607,553,304 | | | | | | — | | |
End of period | | | | $ | 1,602,059,160 | | | | | $ | 3,610,269,060 | | | | | $ | 379,254,366 | | | | | $ | 607,553,304 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | 71,250,001 | | | | | | 9,600,001 | | | | | | 29,850,001 | | | | | | — | | |
Shares sold | | | | | 900,000 | | | | | | 81,600,000 | | | | | | — | | | | | | 33,500,001 | | |
Shares redeemed | | | | | (22,750,000) | | | | | | (19,950,000) | | | | | | (6,700,000) | | | | | | (3,650,000) | | |
Shares outstanding, end of period | | | | | 49,400,001 | | | | | | 71,250,001 | | | | | | 23,150,001 | | | | | | 29,850,001 | | |
(1)
Commencement of operations.
(2)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (continued)
| | | ARK Transparency ETF | | | The 3D Printing ETF | |
| | | December 8, 2021(1) to January 31, 2022 | | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | |
OPERATIONS: | | | | | | | | | | | | | | | | | | | |
Net investment income (loss)(2) | | | | $ | 26,443 | | | | | $ | (596,712) | | | | | $ | 15,921 | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (9,827) | | | | | | (70,364,185) | | | | | | 37,422,039 | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (2,974,767) | | | | | | (21,940,269) | | | | | | (65,606,758) | | |
Net decrease in net assets resulting from operations | | | | | (2,958,151) | | | | | | (92,901,166) | | | | | | (28,168,798) | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (31,360) | | | | | | (6,526) | | | | | | — | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 21,582,673 | | | | | | — | | | | | | 660,321,260 | | |
Cost of shares redeemed | | | | | — | | | | | | (111,292,268) | | | | | | (157,866,003) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | 21,582,673 | | | | | | (111,292,268) | | | | | | 502,455,257 | | |
Increase (decrease) in net assets | | | | | 18,593,162 | | | | | | (204,199,960) | | | | | | 474,286,459 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | |
Beginning of period | | | | | — | | | | | | 515,503,526 | | | | | | 41,217,067 | | |
End of period | | | | $ | 18,593,162 | | | | | $ | 311,303,566 | | | | | $ | 515,503,526 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | — | | | | | | 13,550,001 | | | | | | 1,850,001 | | |
Shares sold | | | | | 1,100,001 | | | | | | — | | | | | | 15,800,000 | | |
Shares redeemed | | | | | — | | | | | | (3,250,000) | | | | | | (4,100,000) | | |
Shares outstanding, end of period | | | | | 1,100,001 | | | | | | 10,300,001 | | | | | | 13,550,001 | | |
(1)
Commencement of operations.
(2)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (concluded)
| | | The ARK Israel Innovative Technology ETF | |
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | |
OPERATIONS: | | | | | | | | | | | | | |
Net investment income (loss)(1) | | | | $ | (201,353) | | | | | $ | 287,036 | | |
Net realized loss on investments and foreign currency transactions | | | | | (18,657,503) | | | | | | (5,519,914) | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (20,045,442) | | | | | | (28,479,379) | | |
Net decrease in net assets resulting from operations | | | | | (38,904,298) | | | | | | (33,712,257) | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (731,187) | | | | | | — | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 1,273,459 | | | | | | 347,145,781 | | |
Cost of shares redeemed | | | | | (76,134,916) | | | | | | (77,840,654) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (74,861,457) | | | | | | 269,305,127 | | |
Increase (decrease) in net assets | | | | | (114,496,942) | | | | | | 235,592,870 | | |
NET ASSETS: | | | | | | | | | | | | | |
Beginning of period | | | | | 283,716,346 | | | | | | 48,123,476 | | |
End of period | | | | $ | 169,219,404 | | | | | $ | 283,716,346 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | 9,375,001 | | | | | | 1,925,001 | | |
Shares sold | | | | | 50,000 | | | | | | 10,100,000 | | |
Shares redeemed | | | | | (2,675,000) | | | | | | (2,650,000) | | |
Shares outstanding, end of period | | | | | 6,750,001 | | | | | | 9,375,001 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Financial Highlights
ARK Genomic Revolution ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | | For the Period Ended July 31, 2017(1) | | | Year Ended August 31, 2016 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 84.40 | | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | | | | $ | 22.24 | | | | | $ | 18.03 | | | | | $ | 20.85 | | |
Net investment loss(2) | | | | | (0.21) | | | | | | (0.24) | | | | | | (0.28) | | | | | | (0.19) | | | | | | (0.18) | | | | | | (0.12) | | | | | | (0.12) | | |
Net realized and unrealized gain (loss) on investments | | | | | (34.09) | | | | | | 31.73 | | | | | | 20.53 | | | | | | 5.80 | | | | | | 7.63 | | | | | | 4.33 | | | | | | (2.70) | | |
Total gain (loss) from investment operations | | | | | (34.30) | | | | | | 31.49 | | | | | | 20.25 | | | | | | 5.61 | | | | | | 7.45 | | | | | | 4.21 | | | | | | (2.82) | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gains | | | | | (0.38) | | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | | | | | — | | | | | | — | | |
Total distributions | | | | | (0.38) | | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | | | | | — | | | | | | — | | |
Net asset value, end of period | | | | $ | 49.72 | | | | | $ | 84.40 | | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | | | | $ | 22.24 | | | | | $ | 18.03 | | |
Market value, end of period | | | | $ | 49.70 | | | | | $ | 84.35 | | | | | $ | 53.70 | | | | | $ | 34.58 | | | | | $ | 29.40 | | | | | $ | 22.29 | | | | | $ | 18.01 | | |
Total Return at Net Asset Value(3) | | | | | (40.71)% | | | | | | 58.48% | | | | | | 60.41% | | | | | | 19.87% | | | | | | 33.80% | | | | | | 23.34% | | | | | | (13.52)% | | |
Total Return at Market Value(3) | | | | | (40.71)% | | | | | | 58.39% | | | | | | 60.05% | | | | | | 20.00% | | | | | | 33.66% | | | | | | 23.77% | | | | | | (14.77)% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 4,092,182 | | | | | $ | 8,588,014 | | | | | $ | 1,589,856 | | | | | $ | 465,966 | | | | | $ | 232,115 | | | | | $ | 23,460 | | | | | $ | 7,302 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75%(4) | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | | | | | 0.90% | | |
Net investment loss(5) | | | | | (0.57)%(4) | | | | | | (0.28)% | | | | | | (0.73)% | | | | | | (0.63)% | | | | | | (0.64)% | | | | | | (0.67)%(4) | | | | | | (0.67)% | | |
Portfolio turnover rate(6) | | | | | 31% | | | | | | 45% | | | | | | 50% | | | | | | 64% | | | | | | 80% | | | | | | 65% | | | | | | 77% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Autonomous Technology & Robotics ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | | For the Period Ended July 31, 2017(1) | | | Year Ended August 31, 2016 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 81.12 | | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | | | | $ | 29.59 | | | | | $ | 21.14 | | | | | $ | 18.33 | | |
Net investment loss(2) | | | | | (0.17) | | | | | | (0.33) | | | | | | (0.13) | | | | | | (0.13) | | | | | | (0.05) | | | | | | (0.07) | | | | | | (0.07) | | |
Net realized and unrealized gain (loss) on investments | | | | | (14.33) | | | | | | 29.42 | | | | | | 19.77 | | | | | | (0.91) | | | | | | 5.89 | | | | | | 8.52 | | | | | | 3.07 | | |
Total gain (loss) from investment operations | | | | | (14.50) | | | | | | 29.09 | | | | | | 19.64 | | | | | | (1.04) | | | | | | 5.84 | | | | | | 8.45 | | | | | | 3.00 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.02) | | | | | | — | | | | | | — | | |
Net realized gains | | | | | (0.61) | | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.48) | | | | | | — | | | | | | (0.19) | | |
Total distributions | | | | | (0.61) | | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.50) | | | | | | — | | | | | | (0.19) | | |
Net asset value, end of period | | | | $ | 66.01 | | | | | $ | 81.12 | | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | | | | $ | 29.59 | | | �� | | $ | 21.14 | | |
Market value, end of period | | | | $ | 65.91 | | | | | $ | 81.18 | | | | | $ | 52.78 | | | | | $ | 33.06 | | | | | $ | 35.01 | | | | | $ | 29.63 | | | | | $ | 21.14 | | |
Total Return at Net Asset Value(3) | | | | | (17.97)% | | | | | | 55.31% | | | | | | 59.43% | | | | | | (2.66)% | | | | | | 19.86% | | | | | | 39.97% | | | | | | 16.43% | | |
Total Return at Market Value(3) | | | | | (18.17)% | | | | | | 55.17% | | | | | | 59.65% | | | | | | (2.84)% | | | | | | 19.98% | | | | | | 40.16% | | | | | | 15.84% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000's omitted) | | | | $ | 1,640,319 | | | | | $ | 2,806,640 | | | | | $ | 447,887 | | | | | $ | 166,897 | | | | | $ | 155,448 | | | | | $ | 66,578 | | | | | $ | 15,853 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75%(4) | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | | | | | 0.89% | | |
Net investment loss(5) | | | | | (0.43)%(4) | | | | | | (0.41)% | | | | | | (0.34)% | | | | | | (0.39)% | | | | | | (0.15)% | | | | | | (0.31)%(4) | | | | | | (0.38)% | | |
Portfolio turnover rate(6) | | | | | 36% | | | | | | 86% | | | | | | 71% | | | | | | 54% | | | | | | 57% | | | | | | 44% | | | | | | 67% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Innovation ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | | For the Period Ended July 31, 2017(1) | | | Year Ended August 31, 2016 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 119.91 | | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | | | | $ | 29.59 | | | | | $ | 20.60 | | | | | $ | 20.06 | | |
Net investment loss(2) | | | | | (0.41) | | | | | | (0.75) | | | | | | (0.38) | | | | | | (0.30) | | | | | | (0.13) | | | | | | (0.15) | | | | | | (0.15) | | |
Net realized and unrealized gain (loss) on investments | | | | | (43.39) | | | | | | 42.33 | | | | | | 32.58 | | | | | | 5.32 | | | | 15.54(3) | | | | | 9.14 | | | | | | 1.16 | | |
Total gain (loss) from investment operations | | | | | (43.80) | | | | | | 41.58 | | | | | | 32.20 | | | | | | 5.02 | | | | | | 15.41 | | | | | | 8.99 | | | | | | 1.01 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.09) | | | | | | — | | | | | | — | | |
Net realized gains | | | | | (0.78) | | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.40) | | | | | | — | | | | | | (0.47) | | |
Total distributions | | | | | (0.78) | | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.49) | | | | | | — | | | | | | (0.47) | | |
Net asset value, end of period | | | | $ | 75.33 | | | | | $ | 119.91 | | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | | | | $ | 29.59 | | | | | $ | 20.60 | | |
Market value, end of period | | | | $ | 75.43 | | | | | $ | 120.00 | | | | | $ | 80.37 | | | | | $ | 48.46 | | | | | $ | 44.55 | | | | | $ | 29.62 | | | | | $ | 20.61 | | |
Total Return at Net Asset Value(4) | | | | | (36.65)% | | | | | | 51.65% | | | | | | 66.82% | | | | | | 12.14% | | | | | | 52.38%(3) | | | | | | 43.64% | | | | | | 4.98% | | |
Total Return at Market Value(4) | | | | | (36.62)% | | | | | | 51.76% | | | | | | 66.47% | | | | | | 12.27% | | | | | | 52.38%(3) | | | | | | 43.72% | | | | | | 4.90% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 12,968,279 | | | | | $ | 22,495,429 | | | | | $ | 6,132,599 | | | | | $ | 1,731,253 | | | | | $ | 1,170,588 | | | | | $ | 85,813 | | | | | $ | 9,271 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75%(5) | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(5) | | | | | | 0.89% | | |
Net investment loss(6) | | | | | (0.74)%(5) | | | | | | (0.63)% | | | | | | (0.70)% | | | | | | (0.67)% | | | | | | (0.33)% | | | | | | (0.67)%(5) | | | | | | (0.76)% | | |
Portfolio turnover rate(7) | | | | | 33% | | | | | | 71% | | | | | | 80% | | | | | | 80% | | | | | | 89% | | | | | | 70% | | | | | | 110% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
The Advisor has reimbursed the Fund $15,999 for a procedural error. The impact was deemed immaterial to net realized and unrealized gain on investments and the Fund’s total return, representing less than $0.005 per share.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Next Generation Internet ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | | For the Period Ended July 31, 2017(1) | | | Year Ended August 31, 2016 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 147.37 | | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | | | | $ | 36.82 | | | | | $ | 24.42 | | | | | $ | 22.02 | | |
Net investment loss(2) | | | | | (0.53) | | | | | | (0.98) | | | | | | (0.45) | | | | | | (0.33) | | | | | | (0.09) | | | | | | (0.17) | | | | | | (0.17) | | |
Net realized and unrealized gain (loss) on investments | | | | | (48.72) | | | | | | 50.76 | | | | | | 47.61 | | | | | | 3.09 | | | | 19.32(3) | | | | | 12.57 | | | | | | 3.10 | | |
Total gain (loss) from investment operations | | | | | (49.25) | | | | | | 49.78 | | | | | | 47.16 | | | | | | 2.76 | | | | | | 19.23 | | | | | | 12.40 | | | | | | 2.93 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.13) | | | | | | — | | | | | | — | | |
Net realized gains | | | | | (3.31) | | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.82) | | | | | | — | | | | | | (0.53) | | |
Total distributions | | | | | (3.31) | | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.95) | | | | | | — | | | | | | (0.53) | | |
Net asset value, end of period | | | | $ | 94.81 | | | | | $ | 147.37 | | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | | | | $ | 36.82 | | | | | $ | 24.42 | | |
Market value, end of period | | | | $ | 94.85 | | | | | $ | 147.55 | | | | | $ | 99.49 | | | | | $ | 52.48 | | | | | $ | 55.08 | | | | | $ | 36.85 | | | | | $ | 24.38 | | |
Total Return at Net Asset Value(4) | | | | | (33.86)% | | | | | | 50.06% | | | | | | 90.13% | | | | | | 7.49% | | | | | | 52.71%(3) | | | | | | 50.77% | | | | | | 13.43% | | |
Total Return at Market Value(4) | | | | | (33.92)% | | | | | | 50.24% | | | | | | 89.58% | | | | | | 7.80% | | | | | | 52.53%(3) | | | | | | 51.15% | | | | | | 13.83% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 2,692,692 | | | | | $ | 5,813,640 | | | | | $ | 1,920,045 | | | | | $ | 431,660 | | | | | $ | 672,276 | | | | | $ | 68,109 | | | | | $ | 14,654 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75%(5) | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(5) | | | | | | 0.89% | | |
Net investment loss(6) | | | | | (0.75)%(5) | | | | | | (0.69)% | | | | | | (0.68)% | | | | | | (0.63)% | | | | | | (0.18)% | | | | | | (0.62)%(5) | | | | | | (0.78)% | | |
Portfolio turnover rate(7) | | | | | 43% | | | | | | 120% | | | | | | 93% | | | | | | 92% | | | | | | 68% | | | | | | 52% | | | | | | 86% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
The Advisor has reimbursed the Fund $13,774 for a procedural error. The impact was deemed immaterial to net realized and unrealized gain on investments and the Fund’s total return, representing less than $0.005 per share.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Fintech Innovation ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | For the Period February 4, 2019(1) through July 31, 2019 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 50.67 | | | | | $ | 36.18 | | | | | $ | 22.84 | | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.16) | | | | | | (0.30) | | | | | | (0.10) | | | | | | (0.03) | | |
Net realized and unrealized gain (loss) on investments | | | | | (18.08) | | | | | | 14.97 | | | | | | 13.74 | | | | | | 2.87 | | |
Total gain (loss) from investment operations | | | | | (18.24) | | | | | | 14.67 | | | | | | 13.64 | | | | | | 2.84 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gains | | | | | — | | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
Total distributions | | | | | — | | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
Net asset value, end of period | | | | $ | 32.43 | | | | | $ | 50.67 | | | | | $ | 36.18 | | | | | $ | 22.84 | | |
Market value, end of period | | | | $ | 32.50 | | | | | $ | 50.68 | | | | | $ | 36.26 | | | | | $ | 22.86 | | |
Total Return at Net Asset Value(3) | | | | | (36.00)% | | | | | | 40.58% | | | | | | 60.36% | | | | | | 14.21% | | |
Total Return at Market Value(3) | | | | | (35.87)% | | | | | | 40.29% | | | | | | 60.59% | | | | | | 14.30% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 1,602,059 | | | | | $ | 3,610,269 | | | | | $ | 347,337 | | | | | $ | 74,233 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75%(4) | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | |
Net investment loss(5) | | | | | (0.65)%(4) | | | | | | (0.60)% | | | | | | (0.40)% | | | | | | (0.24)%(4) | | |
Portfolio turnover rate(6) | | | | | 44% | | | | | | 78% | | | | | | 55% | | | | | | 22% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Space Exploration & Innovation ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | For the Period March 30, 2021(1) through July 31, 2021 | |
Per Share Data: | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 20.35 | | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.02) | | | | | | (0.02) | | |
Net realized and unrealized loss on investments | | | | | (3.95) | | | | | | 0.37 | | |
Total loss from investment operations | | | | | (3.97) | | | | | | 0.35 | | |
Total distributions | | | | | — | | | | | | — | | |
Net asset value, end of period | | | | $ | 16.38 | | | | | $ | 20.35 | | |
Market value, end of period | | | | $ | 16.40 | | | | | $ | 20.34 | | |
Total Return at Net Asset Value(3) | | | | | (19.51)% | | | | | | 1.77% | | |
Total Return at Market Value(3) | | | | | (19.37)% | | | | | | 1.70% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 379,254 | | | | | $ | 607,553 | | |
Ratio to average net assets of: | | | | | | | | | | | | | |
Expenses, prior to expense waivers and reimbursements | | | | | 0.75%(4) | | | | | | 0.75%(4) | | |
Expenses, net of expense waivers and reimbursements | | | | | 0.70%(4) | | | | | | 0.71%(4) | | |
Net investment loss(5) | | | | | (0.24)%(4) | | | | | | (0.26)%(4) | | |
Portfolio turnover rate(6) | | | | | 29% | | | | | | 46% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Transparency ETF
For a share outstanding throughout each period presented.
| | | For the Period December 8, 2021(1) through January 31, 2022 | |
Per Share Data: | | | | | | | |
Net asset value, beginning of period | | | | $ | 20.00 | | |
Net investment income(2) | | | | | 0.03 | | |
Net realized and unrealized loss on investments | | | | | (3.10) | | |
Total loss from investment operations | | | | | (3.07) | | |
Distributions to shareholders: | | | | | | | |
Net investment income | | | | | (0.03) | | |
Total distributions | | | | | (0.03) | | |
Net asset value, end of period | | | | $ | 16.90 | | |
Market value, end of period | | | | $ | 16.89 | | |
Total Return at Net Asset Value(3) | | | | | (15.35)% | | |
Total Return at Market Value(3) | | | | | (15.41)% | | |
Ratios/Supplemental Data: | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 18,593 | | |
Ratio to average net assets of: | | | | | | | |
Expenses | | | | | 0.55%(4) | | |
Net investment income(5) | | | | | 1.01%(4) | | |
Portfolio turnover rate(6) | | | | | 41% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment income represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | | For the Period Ended July 31, 2017(1) | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 38.04 | | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | | | | $ | 25.52 | | | | | $ | 20.81 | | |
Net investment loss(2) | | | | | (0.05) | | | | | | 0.00(3) | | | | | | (0.00)(3) | | | | | | (0.01) | | | | | | (0.04) | | | | | | (0.03) | | |
Net realized and unrealized gain (loss) on investments | | | | | (7.77) | | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.01) | | | | | | (0.73) | | | | | | 4.74 | | |
Total gain (loss) from investment operations | | | | | (7.82) | | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.02) | | | | | | (0.77) | | | | | | 4.71 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | (0.00)(3) | | | | | | — | | | | | | (0.01) | | | | | | — | | | | | | — | | | | | | (0.00)(3) | | |
Net realized gains | | | | | — | | | | | | — | | | | | | — | | | | | | (0.16) | | | | | | (0.53) | | | | | | — | | |
Total distributions | | | | | (0.00) | | | | | | — | | | | | | (0.01) | | | | | | (0.16) | | | | | | (0.53) | | | | | | — | | |
Net asset value, end of period | | | | $ | 30.22 | | | | | $ | 38.04 | | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | | | | $ | 25.52 | | |
Market value, end of period | | | | $ | 30.19 | | | | | $ | 38.00 | | | | | $ | 22.16 | | | | | $ | 22.25 | | | | | $ | 24.32 | | | | | $ | 25.52 | | |
Total Return at Net Asset Value(4) | | | | | (20.56)% | | | | | | 70.76% | | | | | | 1.15% | | | | | | (8.25)% | | | | | | (3.05)% | | | | | | 22.64% | | |
Total Return at Market Value(4) | | | | | (20.55)% | | | | | | 71.48% | | | | | | (0.34)% | | | | | | (7.76)% | | | | | | (2.64)% | | | | | | 22.11% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 311,304 | | | | | $ | 515,504 | | | | | $ | 41,217 | | | | | $ | 39,672 | | | | | $ | 47,220 | | | | | $ | 35,726 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.66%(5) | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66%(5) | | |
Net investment loss(6) | | | | | (0.26)%(5) | | | | | | 0.00%(7) | | | | | | 0.00%(7) | | | | | | (0.04)% | | | | | | (0.17)% | | | | | | (0.14)%(5) | | |
Portfolio turnover rate(8) | | | | | 21% | | | | | | 59% | | | | | | 37% | | | | | | 51% | | | | | | 53% | | | | | | 65% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
Amount represents less than $0.005.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Amount represents less than 0.00%.
(8)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (concluded)
The ARK Israel Innovative Technology ETF
For a share outstanding throughout each period presented.
| | | Six Months Ended January 31, 2022 (Unaudited) | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | For the Period December 5, 2017(1) through July 31, 2018 | |
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 30.26 | | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | | | | $ | 20.00 | | |
Net investment income (loss)(2) | | | | | (0.02) | | | | | | 0.05 | | | | | | (0.03) | | | | | | 0.08 | | | | | | (0.00)(3) | | |
Net realized and unrealized gain (loss) on investments | | | | | (5.07) | | | | | | 5.21 | | | | | | 4.97 | | | | | | 0.18 | | | | | | 0.85 | | |
Total gain (loss) from investment operations | | | | | (5.09) | | | | | | 5.26 | | | | | | 4.94 | | | | | | 0.26 | | | | | | 0.85 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | (0.10) | | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
Total distributions | | | | | (0.10) | | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
Net asset value, end of period | | | | $ | 25.07 | | | | | $ | 30.26 | | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | |
Market value, end of period | | | | $ | 25.09 | | | | | $ | 30.15 | | | | | $ | 24.74 | | | | | $ | 20.64 | | | | | $ | 21.04 | | |
Total Return at Net Asset Value(4) | | | | | (16.88)% | | | | | | 21.06% | | | | | | 24.31% | | | | | | 1.57% | | | | | | 4.27% | | |
Total Return at Market Value(4) | | | | | (16.50)% | | | | | | 21.87% | | | | | | 22.41% | | | | | | 1.20% | | | | | | 5.20% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 169,219 | | | | | $ | 283,716 | | | | | $ | 48,123 | | | | | $ | 19,512 | | | | | $ | 21,896 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.49%(5) | | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49%(5) | | |
Net investment income (loss)(6) | | | | | (0.16)%(5) | | | | | | 0.15% | | | | | | (0.14)% | | | | | | 0.37% | | | | | | (0.03)%(5) | | |
Portfolio turnover rate(7) | | | | | 29% | | | | | | 88% | | | | | | 86% | | | | | | 57% | | | | | | 40% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Amount represents less than $0.005.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Notes to Financial Statements
January 31, 2022 (Unaudited)
1. Organization
ARK ETF Trust (“Trust”) is an open-end management investment company registered under the Investment Company Act of 1940, as amended
(“1940 Act”). The Trust was organized as a Delaware statutory trust on June 7, 2013. The Trust consists of nine (9) investment portfolios: ARK
Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK
Fintech Innovation ETF, ARK Space Exploration & Innovation ETF, ARK Transparency ETF, The 3D Printing ETF, and The ARK Israel Innovative Technology ETF (each, a “Fund” and collectively, “Funds”). Each Fund is classified as a non-diversified management investment company under the 1940 Act.
The investment objective of the ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK
Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF is long-term growth of capital.
ARK Transparency ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Transparency IndexTM. The 3D Printing ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Total 3D-Printing Index. The ARK Israel Innovative Technology ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israel Innovation Index. There can be no assurance that the Funds will achieve their respective investment objectives.
The Trust’s fiscal and tax reporting period is July 31.
2. Significant Accounting Policies
These financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which require management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amount of increase and decrease in net assets from operations during the fiscal period. Actual amounts could differ from these estimates. The Trust is an investment company and follows the investment company accounting standards and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standard Codification (“ASC”) Topic 946, “Financial Services — Investment Companies”. The following summarizes the significant accounting policies of the Funds:
Investment Valuation
The values of each Fund’s securities are based on such securities’ closing prices on the principal market on which the securities are traded. Such valuations would typically be categorized as Level 1 in the fair value hierarchy. If a security’s market price is not readily available or does not otherwise accurately reflect the market value of such security, the security will be fair valued by ARK Investment Management LLC (“Advisor”) in accordance with the Trust’s valuation policies and procedures that were approved by the Board of Trustees of the Trust (“Board”). Each Fund may use fair value pricing in a variety of circumstances, including but not limited to, situations when the value of a Fund’s security has been materially affected by events occurring after the close of the market on which such security is principally traded (such as a corporate action or other news that may materially affect the price of such security) or trading in such security has been suspended or halted. Such valuations would typically be categorized as Level 2 or Level 3 in the fair value hierarchy. Fair value pricing involves subjective judgments and it is possible that a fair value determination for a security could be materially different than the value that could be realized upon the sale of such security.
Investment Transactions
Investment transactions are accounted for on the trade date. Realized gains and losses on sales of investment securities are calculated using the identified cost method. Dividend income is recognized on the ex-dividend date, except for certain foreign dividends that may be recorded as soon as such information becomes available. Interest income and expenses are recognized on the accrual basis.
Dividend Distributions
Distributions to shareholders are recorded on the ex-dividend date and are determined in accordance with federal income tax regulations, which
may differ from U.S. GAAP. Each Fund distributes all or substantially all of its net investment income to shareholders in the form of dividends.
Currency Translation
Assets and liabilities, including investment securities, denominated in currencies other than U.S. dollars are translated into U.S. dollars at the exchange rates supplied by one or more pricing vendors on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the exchange rates on the dates of such transactions.
Notes to Financial Statements (continued)
January 31, 2022 (Unaudited)
The effects of changes in exchange rates on investment securities are included with the net realized gain or loss and net unrealized appreciation or depreciation on investments in each Fund’s statement of operations. The realized gain or loss and unrealized appreciation or depreciation resulting from all other transactions denominated in currencies other than U.S. dollars are disclosed separately.
3. Management and Other Agreements
Management
The ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF, each pay the Advisor a fee calculated daily and payable monthly at an annual rate (stated as a percentage of the average daily net assets of the Fund) of 0.75% (“Management Fee”) in return for providing investment management and supervisory services under a comprehensive unitary structure. The ARK Transparency ETF pays the Advisor a Management Fee of 0.55% in return for providing investment advisory and supervisory services under a comprehensive structure. The 3D Printing ETF pays the Advisor a Management Fee of 0.65% in return for providing investment management and supervisory services under a comprehensive unitary structure. The ARK Israel Innovative Technology ETF pays the Advisor a Management Fee of 0.48% in return for providing investment management and supervisory services under a comprehensive unitary structure. Subject to the supervision of the Board, the Advisor provides investment management services to each Fund and provides, or causes to be furnished, all supervisory and other services reasonably necessary for the operation of each Fund and also bears the costs of various third-party services required by the Funds, including administration, certain custody, audit, legal, transfer agency, and printing costs. In addition to the Management Fee, each Fund bears other fees and expenses, such as taxes and governmental fees, brokerage fees, commissions and other transaction expenses, certain foreign custodial fees and expenses, costs of borrowing money, including interest expenses, and extraordinary expenses (such as litigation and indemnification expenses).
The Advisor has agreed to reduce their Management Fee for the ARK Space Exploration & Innovation ETF as a result of its investment in The 3D Printing ETF. As such, the Management Fees in the Statement of Operations have been reduced by $136,454.
Administrator, Custodian, Transfer Agent and Accounting Agent
The Bank of New York Mellon is the administrator for the Funds, the custodian of the Funds’ assets and provides transfer agency, fund accounting and various administrative services to the Funds (in each capacity, “Administrator,” “Custodian,” “Transfer Agent” or “Accounting Agent”). The Bank of New York Mellon is a subsidiary of The Bank of New York Mellon Corporation, a financial holding company.
Distribution
Foreside Fund Services, LLC serves as the Funds’ distributor (“Distributor”). The Trust has adopted a distribution and service plan (“Rule 12b-1 Plan”) pursuant to Rule 12b-1 under the 1940 Act. Under the Rule 12b-1 Plan, each Fund is authorized to pay distribution fees in connection with the sale and distribution of its shares and pay service fees in connection with the provision of ongoing services to shareholders. To date, the Rule 12b-1 Plan has not been implemented for the Funds and there is no current intention to implement the Rule 12b-1 Plan.
Board of Trustees
Effective January 1, 2022, each Independent Trustee receives an annual retainer fee of $230,000 for services provided as a Trustee of the Trust, plus out-of-pocket expenses related to attendance at Board and Committee Meetings. The Chairs of the Board and of the Audit Committee each also receive an additional annual retainer fee of $60,000 and $20,000, respectively, for their service as such. Prior to this date, each Independent Trustee received an annual retainer fee of $170,000 for services provided as a Trustee of the Trust, plus out-of-pocket expenses related to attendance at Board and Committee Meetings. The Chairs of the Board and of the Audit Committee each also received an additional annual retainer fee of $25,000 and $15,000, respectively, for their service as such.
4. Creation and Redemption Transactions
As of January 31, 2022, there were an unlimited number of shares of beneficial interest without par value authorized by the Trust. Individual shares of a Fund may only be purchased and sold at market prices on a national securities exchange through a broker-dealer. Such transactions may be subject to customary commission rates imposed by the broker-dealer, and market prices for a Fund’s shares may be at, above or below its net asset value (“NAV”) depending on the premium or discount at which the Fund’s shares trade.
Each Fund issues and redeems shares at its NAV only in a large specified number of shares each called a “Creation Unit,” or multiples thereof, and only with “authorized participants” who have entered into contractual arrangements with the Distributor. A Creation Unit consists of 50,000 shares (25,000 shares with respect to the ARK Israel Innovative Technology ETF). Except when aggregated in Creation Units, shares of
Notes to Financial Statements (continued)
January 31, 2022 (Unaudited)
each Fund are not redeemable. Transactions in shares for each Fund are disclosed in detail in the Statements of Changes in Net Assets. The consideration for a purchase of Creation Units generally consists of the in-kind deposit of specified securities and an amount of cash or, as permitted or required by a Fund, of cash. A fixed transaction fee is imposed on each creation and redemption transaction. In addition, a variable charge for certain creation and redemption transactions may be imposed.
5. Investment Transactions
The cost of purchases and the proceeds from sales of investment securities (excluding in-kind subscriptions and redemptions and short-term investments) for the period ended January 31, 2022 were as follows:
Fund | | | Purchases | | | Sales | |
ARK Genomic Revolution ETF | | | | $ | 2,022,048,449 | | | | | $ | 2,064,825,785 | | |
ARK Autonomous Technology & Robotics ETF | | | | | 888,180,305 | | | | | | 856,053,818 | | |
ARK Innovation ETF | | | | | 6,245,888,272 | | | | | | 6,353,707,519 | | |
ARK Next Generation Internet ETF | | | | | 2,065,868,642 | | | | | | 2,196,133,958 | | |
ARK Fintech Innovation ETF | | | | | 1,305,458,988 | | | | | | 1,336,285,950 | | |
ARK Space Exploration & Innovation ETF | | | | | 148,215,685 | | | | | | 157,045,932 | | |
ARK Transparency ETF | | | | | 5,495,928 | | | | | | 5,498,064 | | |
The 3D Printing ETF | | | | | 93,439,407 | | | | | | 108,189,003 | | |
The ARK Israel Innovative Technology ETF | | | | | 71,635,323 | | | | | | 73,460,451 | | |
For the period ended January 31, 2022, the cost of in-kind subscriptions and the proceeds from in-kind redemptions were as follows:
| | | In-Kind | |
Fund | | | Subscriptions | | | Redemptions | |
ARK Genomic Revolution ETF | | | | $ | 1,396,540,030 | | | | | $ | 2,742,701,336 | | |
ARK Autonomous Technology & Robotics ETF | | | | | 27,308,175 | | | | | | 776,012,364 | | |
ARK Innovation ETF | | | | | 8,094,433,510 | | | | | | 10,073,848,590 | | |
ARK Next Generation Internet ETF | | | | | 554,698,701 | | | | | | 1,962,191,062 | | |
ARK Fintech Innovation ETF | | | | | 34,831,431 | | | | | | 1,002,658,051 | | |
ARK Space Exploration & Innovation ETF | | | | | — | | | | | | 121,055,997 | | |
ARK Transparency ETF | | | | | 21,537,641 | | | | | | — | | |
The 3D Printing ETF | | | | | — | | | | | | 107,432,504 | | |
The ARK Israel Innovative Technology ETF | | | | | 1,250,175 | | | | | | 71,176,522 | | |
6. Federal Income Tax
Each Fund intends to qualify as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended. If so qualified, a Fund will not be subject to federal income tax to the extent it distributes substantially all of its net investment income and net capital gains to its shareholders. Accounting for Uncertainty in Income Taxes provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements, and requires the evaluation of tax positions taken or expected to be taken in the course of preparing a Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the more-than-likely-than-not threshold would be recorded as a tax benefit or expense in the current year. Interest and penalty related to income taxes would be recorded as income tax expense. The management of the Funds is required to analyze all open tax years (2019 – 2021), as defined by IRS statute of limitations, for all major jurisdictions, including federal tax authorities and certain state tax authorities. As of July 31, 2021, the Funds did not have a liability for any unrecognized tax benefits. The Funds have no examination in progress and are not aware of any tax positions for which it is reasonably possible that the amounts of unrecognized tax benefits will significantly change in the next twelve months.
Notes to Financial Statements (continued)
January 31, 2022 (Unaudited)
At July 31, 2021, the approximate cost of investments and net unrealized appreciation (depreciation) for federal income tax purposes was as
follows:
Fund | | | Cost | | | Gross Unrealized Appreciation | | | Gross Unrealized Depreciation | | | Net Unrealized Appreciation (Depreciation) | |
ARK Genomic Revolution ETF | | | | $ | 9,270,375,013 | | | | | $ | 762,324,119 | | | | | $ | (1,439,848,029) | | | | | $ | (677,523,910) | | |
ARK Autonomous Technology & Robotics ETF | | | | | 2,838,248,197 | | | | | | 198,776,586 | | | | | | (222,356,196) | | | | | | (23,579,610) | | |
ARK Innovation ETF | | | | | 21,910,871,348 | | | | | | 2,420,186,414 | | | | | | (1,815,532,552) | | | | | | 604,653,862 | | |
ARK Next Generation Internet ETF | | | | | 5,619,999,803 | | | | | | 630,161,935 | | | | | | (422,968,595) | | | | | | 207,193,340 | | |
ARK Fintech Innovation ETF | | | | | 3,657,089,669 | | | | | | 286,601,312 | | | | | | (331,425,555) | | | | | | (44,824,243) | | |
ARK Space Exploration & Innovation ETF | | | | | 614,076,444 | | | | | | 23,230,607 | | | | | | (25,165,785) | | | | | | (1,935,178) | | |
The 3D Printing ETF | | | | | 577,641,235 | | | | | | 43,618,201 | | | | | | (105,755,795) | | | | | | (62,137,594) | | |
The ARK Israel Innovative Technology ETF | | | | | 311,341,527 | | | | | | 17,689,915 | | | | | | (44,891,520) | | | | | | (27,201,605) | | |
The differences between book-basis and tax-basis components of net assets are primarily attributable to tax deferral of losses on wash sales, non-REIT income and basis adjustments, grantor trust adjustments, and undistributed short-term capital gains treated as ordinary income for tax purposes.
At July 31, 2021, for Federal income tax purposes, the Funds have capital loss carryforwards available as shown in the table below, to the extent provided by regulations, to offset future capital gains for an unlimited period. To the extent that these capital loss carryforwards are used to offset future capital gains, it is probable that the capital gains so offset will not be distributed to shareholders.
| | | Short-Term | | | Long-Term | | | Total Amount | |
ARK Genomic Revolution ETF | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
ARK Autonomous Technology & Robotics ETF | | | | | — | | | | | | — | | | | | | — | | |
ARK Innovation ETF | | | | | — | | | | | | — | | | | | | — | | |
ARK Next Generation Internet ETF | | | | | — | | | | | | — | | | | | | — | | |
ARK Fintech Innovation ETF | | | | | 183,568,907 | | | | | | — | | | | | | 183,568,907 | | |
ARK Space Exploration & Innovation ETF | | | | | 10,320,213 | | | | | | — | | | | | | 10,320,213 | | |
The 3D Printing ETF | | | | | 13,257,088 | | | | | | 6,168,021 | | | | | | 19,425,109 | | |
The ARK Israel Innovative Technology ETF | | | | | 17,719,738 | | | | | | 387,450 | | | | | | 18,107,188 | | |
7. Indemnification Obligations
The Funds have a variety of indemnification obligations under contracts with their service providers. The Funds’ maximum exposure under these arrangements is unknown. However, the Funds have not had prior claims or losses pursuant to these contracts and expect the risk of loss to be remote.
8. Investment Risks
Concentration Risk: The ARK Autonomous Technology & Robotics ETF will be concentrated in securities of issuers having their principal business activities in groups of industries in the industrials and information technology sectors, although it will not concentrate in any specific industry. The ARK Fintech Innovation ETF will be concentrated in securities of issuers having their principal business activities in the communication, technology and financials group of industries. The ARK Genomic Revolution ETF will be concentrated in securities of issuers having their principal business activities in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The ARK Next Generation Internet ETF will be concentrated in securities of issuers having their principal business activities in the internet information provider and catalog and mail order house industry. ARK Space Exploration & Innovation ETF will concentrate in securities of issuers having their principal business activities in groups of industries in the (i) industrials sector and (ii) information technology sector. The 3D Printing ETF, the ARK Transparency ETF and the ARK Israel Innovative Technology ETF may each invest 25% or more of the value of its respective net assets in securities of issuers in any one industry or group of industries if the applicable index that the Fund replicates concentrates in an industry or group of industries. This concentration limit does not apply to securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities. The ARK Innovation ETF will not be concentrated in any industry.
As of January 31, 2022, the ARK Genomic Revolution ETF had more than 25% of its assets invested in the biotechnology industry, the ARK Fintech Innovation ETF had more than 25% of its assets invested in IT services industry, the ARK Space Exploration & Innovation ETF had more than 25% of its assets invested in the aerospace & defense industry, the ARK Transparency ETF had more than 25% of its assets invested in software industry, and the ARK Israel Innovative Technology ETF had more than 25% of its assets invested in the software industry. To the
Notes to Financial Statements (concluded)
January 31, 2022 (Unaudited)
extent a Fund’s holdings are concentrated in a particular industry or group of industries, adverse market conditions affecting those industries may have a more significant impact on the Fund than they would on a Fund investing in a broader range of securities and the value of the Fund’s shares may fluctuate more than shares of a fund investing in a broader range of securities.
The Funds’ prospectuses contain additional information regarding the risks associated with an investment in a Fund.
Market Risk: The outbreak of COVID-19, a novel coronavirus disease, has negatively affected economies, markets and individual companies throughout the world, including those in which the Funds invest. The effects of this pandemic to public health and business and market conditions, including exchange trading suspensions and closures may continue to have a significant negative impact on the performance of a Fund’s investments, increase a Fund’s volatility, negatively impact a Fund’s arbitrage and pricing mechanisms, exacerbate pre-existing political, social and economic risks to a Fund, and negatively impact broad segments of businesses and populations. A Fund’s operations may be interrupted as a result, which may contribute to the negative impact on investment performance. In addition, governments, their regulatory agencies, or self-regulatory organizations may take actions in response to the pandemic that affect the instruments in which a Fund invests, or the issuers of such instruments, in ways that could have a significant negative impact on the Fund’s investment performance. The full impact of the COVID-19 pandemic, or other future epidemics or pandemics, is currently unknown.
9. Subsequent Events
Subsequent events occurring after the date of this Report have been evaluated for potential impact to this Report through the date the Report was issued, and it has been determined that no events have occurred that require disclosure.
Supplemental Information (Unaudited)
Quarterly Portfolio Schedule. The ARK ETF Trust files with the Securities and Exchange Commission on Form N-PORT the complete schedule of portfolio holdings for each ARK ETF for the first and third quarters of each fiscal year. The ARK ETF Trust’s Forms N-PORT are available on the Securities and Exchange Commission’s website at www.sec.gov. Copies of the filings are available without charge, upon request, by calling 1-212-426-7040. In addition, each ARK ETF’s current portfolio holdings are updated daily and are available on our website, www.ark-funds.com.
Proxy Voting Policies and Procedures. A description of ARK Investment Management LLC’s proxy voting policies and procedures, which are applicable to the ARK ETFs, is available without charge, upon request, by calling 1-212-426-7040 collect or visiting our website at www.ark-funds.com or the Securities and Exchange Commission’s website at www.sec.gov.
Proxy Voting Record. The ARK ETFs file with the Securities and Exchange Commission their proxy voting records on Form N-PX for each 12 month period ending June 30. Form N-PX must be filed each year by August 31. The most recent Form N-PX or voting record information is available without charge, upon request, by calling 1-212-426-7040 collect or visiting the Securities and Exchange Commission’s website at www.sec.gov.
Premium/Discount Information. Information about the difference between daily market prices on the secondary market for shares of each ARK ETF and the ARK ETF’s net asset value can be found on our website, www.ark-funds.com.
Board Approval of Management Agreements (Unaudited)
Board Approval of Management Agreements for ARK Transparency ETF
Under section 15(c) of the Investment Company Act of 1940 (“1940 Act”), the ARK ETF Trust’s (“Trust”) Board of Trustees (“Trustees” or “Board”), including a majority of Trustees who are not “interested persons” of the Trust (as that term is defined in the 1940 Act) (“Independent Trustees”), was required to consider whether to approve the proposed (i) Supervision Agreement between the Trust and ARK Investment Management, LLC (“ARK”) on behalf of ARK Transparency ETF (the “Fund”); and (ii) Investment Advisory Agreement between the Trust and ARK (collectively, “Management Agreements”) on behalf of the Fund. At the September 23, 2021 meeting of the Board (the “Meeting”), which was held via video conference, the Board, including a majority of the Independent Trustees, initially approved the proposed Management Agreements on behalf of the Fund.
In advance of the Meeting, the Independent Trustees and their counsel reviewed and discussed information provided by ARK that they determined was reasonably necessary to evaluate the terms of the proposed Management Agreements. The Independent Trustees also considered other information previously provided to the Board by ARK as part of its evaluation process. Prior to voting on the proposed Management Agreements on behalf of the Fund, the Independent Trustees met in executive session with ARK’s senior management and also met in private sessions with their counsel at which time no representatives of ARK were present.
After the presentation of relevant information by ARK’s senior management and extensive discussions prior to and at the Meeting, the Trustees, including the Independent Trustees voting separately, unanimously approved the proposed Management Agreements on behalf of the Fund. The determination made by all of the Trustees to approve the proposed Management Agreements was made on the basis of each Trustee’s business judgment after considering all of the information presented to them. Individual Trustees may have given different weights to certain factors and assigned various degrees of materiality to information received in connection with their evaluation of the proposed Management Agreements. In approving the proposed Management Agreements on behalf of the Fund, the following factors were considered by the Trustees, and no one factor was determinative:
(a) Nature, Extent and Quality of Services. The Trustees considered the nature, extent and quality of the services that ARK would provide to the Fund under the proposed Management Agreements, including: (i) the qualifications of the portfolio manager, analysts and other key personnel of ARK who would provide the supervisory and investment advisory services to the Fund; and (ii) the terms of the proposed Management Agreements. The Trustees considered ARK’s senior management’s discussion of the various duties and responsibilities of ARK under the proposed Management Agreements, noting that the Fund would seek to provide investment results that closely correspond, before fees and expenses, to the performance of the Fund’s benchmark index. The Trustees also considered the organizational structure of ARK, the quality of the investment, administrative, operations, and legal personnel that ARK currently provides to other series of the Trust overseen by the Board and would provide to the Fund, and ARK’s proposed management of the operations of the Fund.
Based on these and other factors, the Trustees concluded that the nature, extent and quality of the supervisory and investment advisory services that would be provided to the Fund by ARK pursuant to the proposed Management Agreements were satisfactory and supported the decision of the Trustees to approve the proposed Management Agreements with respect to the Fund.
(b) Performance. The Trustees noted that as a newly established series of the Trust, the Fund had no performance history that they could review. The Board took into account certain information concerning the Fund’s proposed benchmark index, including its construction and composition. In addition, the Board considered ARK’s investment management operations and capabilities, as well as ARK’s management of two other series of the Trust that, similar to the Fund, seek to provide investment results that closely correspond, before fees and expenses, to their respective benchmark indexes.
(c) Proposed Fees and Estimated Expenses. The Trustees considered the proposed fees payable by the Fund to ARK under the proposed Management Agreements in relation to the services to be received by the Fund from ARK. In evaluating the reasonableness of the proposed fees payable by the Fund, the Trustees noted that the proposed fees generally were in line with the fees paid by other series of the Trust, including the two series that seek to provide investment results that closely correspond, before fees and expenses, to their respective benchmark indexes. The Board also took into account the Fund’s proposed fee and expense structure, noting that under that structure ARK would generally pay all non-management expenses of the Fund other than certain excluded expenses, such taxes and governmental fees, brokerage fees, commissions and other transaction expenses, certain foreign custodial fees and expenses, costs of borrowing money, including interest expenses, and extraordinary expenses.
The Trustees concluded that the proposed fees that would be paid by the Fund under the Management Agreements were reasonable considering the services that the Fund would receive and the fees paid by comparable series of the Trust.
(d) Potential Economies of Scale. The Trustees considered ARK’s senior management’s discussion of the proposed fee and expense structure for the Fund and noted that the proposed fee and expense structure effectively acts as a cap on the fees and expenses (excluding certain specific investment-related and extraordinary fees and expenses) that are borne by the Fund. The Trustees noted that ARK would bear most of the
Board Approval of Management Agreements (Unaudited)
ordinary fees and expenses of the Fund, including the costs to license the Fund’s benchmark index. The Trustees also noted that, although there currently are no breakpoints in the proposed fee structure for the Fund, if the Fund’s assets increase over time, the Fund might realize other economies of scale if assets increase proportionally more than certain other expenses.
Based on these considerations, the Trustees concluded that adding breakpoints at specified levels to the Fund’s proposed fee structure was not appropriate at that time.
(e) Costs and Profitability. In considering the anticipated profitability of the Fund to ARK, the Trustees noted the challenges in evaluating the profitability of the Fund given that it had not yet commenced operations and there were not comparable investment products currently being offered. The Trustees noted, however, that under the Fund’s proposed fee and expense structure, the Fund would not be profitable to ARK until such time as the Fund had achieved scale.
(f) Indirect Benefits. The Trustees then considered the extent to which ARK may derive any ancillary or indirect benefits from the Fund’s operations as a result of ARK’s relationship with the Fund. The Trustees noted that ARK’s reputation as an asset manager could benefit from the performance of the Fund, which has the potential to aid ARK in gathering assets for its non-fund business operations. The Trustees also considered that ARK’s affiliates were likely to benefit if the Fund has a positive reception and gains popularity.
The Board concluded that the nature and amount of any indirect benefits that ARK and its affiliates would receive from ARK’s relationship with the Fund are reasonable.
(g) Financial Resources of ARK. The Trustees then considered whether ARK was financially sound and had adequate resources to perform its obligations under the proposed Management Agreements.
Based on the information provided to the Board, the Trustees concluded that ARK had sufficient financial resources necessary to continue to perform its obligations under the Management Agreements.
General Conclusion. Based on its consideration of all of the above factors, and such other information as it deemed appropriate and relevant, the Board concluded that it would be in the best interest of the Fund and its shareholders to approve the proposed the Management Agreements on behalf of the Fund, including the proposed fees payable under those Agreements. Accordingly, the Board, with Independent Trustees voting separately, unanimously approved the proposed Management Agreements with respect to the Fund.
General Information (Unaudited)
Investment Advisor
ARK Investment Management LLC
200 Central Avenue, Suite 1850
St. Petersburg, FL 33701
Administrator, Custodian, Transfer Agent, and Accounting Agent
The Bank of New York Mellon
240 Greenwich Street
New York, NY 10286
Distributor
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, ME 04101
Independent Registered Public Accounting Firm
Tait, Weller & Baker LLP
50 S.16th Street, 29th Floor
Philadelphia, PA 19102
This report is submitted for the general information of the shareholders of each Fund. It is not authorized for distribution to prospective investors unless preceded or accompanied by an effective prospectus, which includes information regarding the Funds’ risks, objectives, fees and expenses, experience of their management, and other information.
ARK Invest | 200 Central Avenue, Suite 1850, St. Petersburg, FL 33701 | 212.426.7040 | info@ark-invest.com | ark-funds.com
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
| (a) | Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1(a) of this form. |
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s board of trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 11. Controls and Procedures.
| (a) | As of a date within 90 days of the filing date of this Form N-CSR, the registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c))) are effective, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)). |
| (b) | There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | ARK ETF Trust |
By (Signature and Title)* | /s/ Catherine D. Wood |
| Catherine D. Wood, Chief Executive Officer and Chief Investment Officer |
| (principal executive officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)* | /s/ Catherine D. Wood |
| Catherine D. Wood, Chief Executive Officer and Chief Investment Officer |
| (principal executive officer) |
By (Signature and Title)* | /s/ William C. Cox |
| William C. Cox, Treasurer and Chief Financial Officer |
| (principal financial officer) |
* Print the name and title of each signing officer under his or her signature